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This thesis aimed to explore the perceptions and practices of key stakeholders regarding research 
conducted in provincial public health facilities. Research plays a vital role in improving health and 
health care globally, as well as in KwaZulu-Natal (KZN), South Africa, where it has resulted in significant 
health gains particularly in the field of HIV/AIDS. However, in spite of a robust regulatory framework 
and guiding documents, health research may be fraught with challenges. In KZN, the Provincial Health 
Research and Ethics Committee (PHREC) is responsible for providing final permission for researchers 
to access public health facilities to conduct their research, or to recruit potential participants from 
these facilities. This permission is based on the support of health managers of public health facilities 
and programmes who provide the first level of permission in the PHREC approval process. This study 
explored the perceptions and practices of researchers and health managers regarding research 
conducted in provincial public health facilities, and regarding their inter-stakeholder relationships. A 
qualitative study design was adopted, using in-depth interviews as the means of data collection. 
Eighteen interviews were conducted – eight with health managers and ten with researchers. 
Interviews were analysed using Thematic Analysis. Three important themes were generated from the 
analysis: varying perceptions around the ‘social value’ of research, strained inter-stakeholder 
relations, and recommendations for strengthening research and relations. Although all participants 
agreed that health research was valuable, researchers tended to place more emphasis on its 
contribution to new knowledge and future beneficiaries, whilst health managers tended to emphasise 
its concrete and current contribution to the functioning of the healthcare system. Respondents 
perceived that their relationships were strained at all stages of the research process. Particular 
concerns included a lack of involvement of health managers in the conceptualization of research 
questions, frustration of researchers with a prolonged, onerous research application process, and 
poor feedback of research results to health managers. Important relationship issues included lack of 
trust, accountability, and transparency. Both stakeholder groups had a shared view regarding how to 
strengthen both the research process and inter-stakeholder relations. There was strong agreement 
on, amongst others, improving communication through more regular, formal and informal meetings, 
and entrenching a culture of research within the KZN Department of Health. The study concludes that 
researchers and health managers had subtly differing perceptions of what makes health research in 
provincial health facilities valuable, and that tensions between these groups were perceived across 
the life-cycle of the research process. The study makes various recommendations on how to build 
stronger relations between stakeholders, in order to facilitate the conduct of high quality research in 
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1.1 BACKGROUND  
 
A critical and contemporary concern in the ethics of health research is how researchers can establish 
meaningful relationships with key stakeholders (MacQueen et al., 2015). Ethics scholars argue that 
researchers should strive to establish relationships with key stakeholders that represent 
“collaborative partnerships” (Emanuel, Wendler, Killen, & Grady, 2004, p. 932). Ethical guidelines 
posit that researchers should strive for relationships that are equitable and premised on the full 
engagement of all those interested in or affected by health research (UNAIDS/AVAC, 2011). It is 
argued that such relationships may have multiple benefits. Such relationships may ensure that the 
research questions are relevant for key stakeholders, including the communities in which the 
research is conducted. They may help to ensure that the research is valued by all those involved in or 
affected by it, and therefore facilitate the conduct of the research itself, as well as the utilisation of 
the research results. Finally, collaborative partnerships exemplify good practice in collaboration that 
may have an impact on broader society (Ross et al., 2010). Ideally, they should be based on mutual 
trust, respect and understanding, transparency, and accountability (UNAIDS/AVAC, 2011). Such 
relationships, however, may not be easy to achieve. They require a meeting of the minds of 
stakeholders with diverse interests and priorities. By definition, they require a level of equality 
between stakeholders that is rare in societies which are inequitable and hierarchical.  
 
National ethics guidelines for health research conducted in South Africa assert that “researchers 
should engage key role players at various stages of planning and conducting research” (National 
Department of Health (NDoH), 2015, p. 16) underscoring the need for researchers to invest in 
collaborative relationships with key stakeholders. However, South African society is deeply 
inequitable (Leibbrandt, Woolard, Finn, & Argent, 2010). Poverty remains pervasive, is concentrated 
largely among black South Africans, and has a profound impact on population health (Coovadia et 
al., 2009). This, together with South Africa’s history of colonisation and apartheid, has important 
implications for the development of collaborative partnerships in health research in the country 
(Barsdorf & Wassenaar 2006). Researchers and physicians are considered in most societies to be 
part of a social elite (Benatar 2002; Christakis 1992). In South Africa, this may be compounded by the 
“legacy of colonialism (which) evokes covert ethnic divisiveness between researchers and subjects” 
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(Benatar, 2002, p. 1134), as well as between researchers and those who control access to sites 
where data will be collected (so-called ‘gatekeepers’) (Broadhead & Rist, 1976; Campbell, Gray, 
Meletis, Abbott, & Silver, 2006; Singh & Wassenaar, 2016) and who may use the results of research.  
 
However, it is crucial that health research in South Africa, and in particular in the province of 
KwaZulu-Natal (KZN), is fostered. KwaZulu-Natal carries a complex burden of disease. The province 
has the highest incidence of TB in the country (1,142 per 100 000) (Day et al., 2012: 89) as well as 
the highest HIV prevalence rate nationally (39.5%) (Day et al., 2012, p. 89). In addition, there are 
emerging epidemics of diseases of lifestyle, and trauma remains one of the most important causes 
of death among young men. Health research is vital to develop new modalities of prevention and 
treatment for this diverse range of health problems, and to support the health system to deliver 
these modalities effectively. Indeed, KwaZulu-Natal is a highly active region in terms of health 
research. It is home to several large and well-funded research organisations such as CAPRISA (Centre 
for the AIDS Programme of Research in South Africa), the Africa Health Research Institute (AHRI), 
units of the South African Medical Research Council (SA MRC), and BroadReach Healthcare, amongst 
others. Groundbreaking research with both local and global impact has been conducted in this 
province, particularly in the field of HIV/AIDS (Abdool Karim et al., 2010; Tanser et al., 2013). 
Research Ethics Committees (RECs) in this province process over 600 applications to conduct health 
research in the province annually, of which approximately 15% are clinical trials (D. Wassenaar, 
personal communication, September 22, 2015). Over and above the importance of health research 
in finding solutions to health problems, some have argued that it is important also because it is 
democratising – that is, the conduct of research (including health research) institutionalises scholarly 
debate that can only benefit society (Benatar, 2002).  
 
South Africa has well-established national health research legislation, normative ethics guidance 
(Cleaton-Jones & Wassenaar, 2010; National Health Research Ethics Council (NHREC), (NDoH, 2015) 
and regulation and credentialing of all RECs by the National Health Research Ethics Council (NHREC). 
However, in spite of these structures and ethics guidelines, the conduct of health research may be 
undermined by the absence of collaborative partnerships between researchers and a key 
stakeholder group, namely the managers of health facilities and programmes, who control access to 
the health facilities hosting research (so-called ‘gate-keepers’) and who are potential users of 




Since 2012, I have been the Chair of the KwaZulu-Natal Provincial Health Research and Ethics 
Committee (KZN PHREC), which is responsible for reviewing and approving the conduct of research 
in public health facilities in the province. My experience in this position has demonstrated that there 
are tensions in the relationships between researchers and health managers in the province. These 
tensions have manifested themselves most visibly in the review of applications to the KZN PHREC to 
conduct clinical trials in provincial health facilities, where processing times have been protracted, 
leading some to argue that the conduct of clinical trials in the province is threatened (Singh & Mills 
2005). ‘Corridor conversations’ to which I am party have revealed that both researchers and health 
managers within the Department of Health experience varying degrees of frustration towards one 
another. I have become increasingly of the view that it is important to understand perceptions 
around these relationships more fully, in order to better promote important health research in the 
province. I was of the view that tense relations may be manifestations of different beliefs about the 
ideal conduct of health research, but did not have a clear understanding of the perceptions of key 
stakeholders regarding research in public health facilities.  
 
Such perceptions, and related practices, are arguably important subjects of research themselves. 
The ‘moral map’ of stakeholders in KwaZulu-Natal is diverse (Prozesky, 2009), and exploring the 
viewpoints of representatives of various groups may help to identify perceived difficulties in 
research in provincial health facilities, as well as contribute to a broader understanding of how 
stakeholders with diverse backgrounds, needs and priorities could work together to ensure excellent 
and useful research. It was in order to develop a better understanding of perceptions and practices 
of research in provincial health facilities, including researcher-health manager relations, and to 
recommend ways to strengthen such relations, that this research was conducted.  
 
1.2 STUDY AIMS 
 
This study had the following aims:  
1. To explore the perceptions and practices of key stakeholders related to research 
conducted in provincial public health facilities, including processes around its planning, 
approval, conduct, dissemination and impact 
2. To explore the perceptions and practices of key stakeholders regarding inter-stakeholder 
relations  
3. To make recommendations to strengthen the ethical conduct of such research, including 




This study adopted a qualitative approach, using in-depth interviews (DiCicco-Bloom & Crabtree, 
2006) to gain a deeper understanding of how stakeholders perceived such research in general, the 
research process and their relationships with other key stakeholders. It was important that the 
approach lend itself to the exploratory nature of this inquiry; where interviewees volunteer their 
own points of view, and are permitted to raise issues freely, and the investigator is allowed to probe 
their views during the data collection process (ibid).  
 
1.3 DISSERTATION OUTLINE 
 
In Chapter 1, the background to the study is presented, with references to important literature and 
including the investigator’s personal experience and rationale for undertaking the study. In Chapter 
2, a review of the literature relevant to the study is presented, which underscores the importance of 
health research, describes the various ethics guidelines available to facilitate the conduct of useful 
health research, and highlights the lack of empirical research into the relationship between the 
‘gatekeepers’ of health facilities in which much health research takes place, and researchers 
themselves. In Chapter 3, the aims and methods of the study are set out; the qualitative approach 
used in the study is described and steps taken to enhance the quality of the study are outlined. In 
Chapter 4, the results of the study are described in terms of the themes that were generated in the 
data analysis. These themes were firstly, varying perceptions of the ‘social value’ of research; 
secondly, strained inter-stakeholder relations; and thirdly strengthening research and relations. In 
Chapter 5, these results are discussed with reference to the relevant literature, both local and 
international. The discussion is structured according to the three themes as presented in the results. 
In Chapter 6, the main conclusions of the study are described, and the implications of the study for 
research in provincial health facilities are considered. Recommendations are made for strengthening 







This chapter sets out to describe the importance of health research. It sets out ethics 
recommendations (in frameworks and ethical guidelines) that researchers engage key stakeholders 
in an early and sustained manner in research, and selected other ethics recommendations. It 
describes the effect of inter-stakeholder relationships on health research. It highlights the gap in 
current knowledge around the role of health managers including as ‘gatekeepers’ of public health 
facilities in KZN, where much health research takes place, and the importance of addressing gaps in 
this knowledge, in order to make recommendations to strengthen research in provincial health 
facilities.  
 
2.1  HEALTH RESEARCH  
 
Research is defined in the Code of Federal Regulations 46.102(d) as “a systematic investigation … 
designed to develop or contribute to generalisable knowledge” (U.S. Department of Health and 
Human Services (USDHHS, 2009) and health research is essentially that which is undertaken to 
better understand human health (Harvard Medical School, 2017). It is a vast field, which includes, 
amongst others, clinical research (the study of disease mechanisms and therapeutic processes in the 
human body), basic (laboratory based) research, and health policy and health systems research (an 
interdisciplinary field that focuses on how societies develop and achieve health goals collectively) 
(WHO, 2017).  
 
Health research involves multiple stakeholders (UNAIDS/AVAC, 2011). Besides researchers 
themselves, the stakeholders involved in health research projects may include the participants in the 
study, the communities from which those participants are drawn, funders, Research Ethics 
Committees (RECs) which review study protocols, research and academic institutions which conduct 
and support research, government departments which utilise research results, and ‘gatekeepers’ 
who control access to the communities or health facilities where the research will take place 
(Campbell et al., 2006). These actors are not passive in the research process, and have their own 
vested interests and expectations. Given the diversity of the field of health research, and the array of 
different actors involved, and their varying interests and priorities, it is not surprising that processes 
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of conceptualising, reviewing, approving, and conducting research, and utilising research results, are 
complex.  
 
2.2  ETHICS GUIDANCE FOR HEALTH RESEARCH 
 
Ethics scholars have developed popular and systematic ethics frameworks for health research. They 
have argued that health researchers should ensure that key stakeholders are engaged in a particular 
kind of relationship with them – a collaborative partnership that allows stakeholders to gain from 
the research, either through the process or the outcomes thereof (Emanuel et al., 2004). 
Collaborative partnerships should span the whole of the research process and involve “sharing 
responsibilities for determining the importance of [the] health problem, assessing the value of [the] 
research, planning, conducting, and overseeing research, and integrating research into the health-
care system” (Emanuel et al., 2004, p. 931). Failure to establish these collaborative partnerships in 
the conduct of research can undermine the entire research process and its outcomes, as 
demonstrated in a number of early HIV prevention trials (Allman, Ditmor, & Kaplan, 2014; Ukpong & 
Peterson, 2009).  
 
It is important that key stakeholders in health research work together in mutual collaboration, and 
useful ethics guidelines have been developed in order to facilitate this (MacQueen, 2012; HIV 
Prevention Trials Network (HPTN), 2009; UNAIDS/AVAC, 2011). The UNAIDS/AVAC Guidelines for 
Good Participatory Practice (2011) define stakeholders in research very broadly - as “individuals, 
groups, organisations, government bodies, or any other individuals or collections of individuals who 
can influence or are affected by the conduct or outcome” of a research study (p. 14). These ethics 
guidelines define stakeholder engagement as the process “through which …. funders, sponsors, and 
implementers build transparent, meaningful, collaborative, and mutually beneficial relationships 
with interested or affected individuals, groups of individuals, or organisations, with the ultimate goal 
of shaping research collectively” (UNAIDS/AVAC, 2011, p. 16). The ethics guidelines emphasise the 
importance of several ‘principles’ that underpin successful stakeholder relationships. These include: 
respect, mutual understanding, integrity, transparency, accountability, and respect for community 
stakeholder autonomy. These guidelines expressly list national and local healthcare authorities as 
key stakeholders. 
 
The history of health research makes it clear that the relationships between researchers and other 
stakeholders have not always been characterised by such attributes (Annas & Grodin, 1998; Brandt 
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1978; Kim, 2012). Increasing realisation of and abhorrence for exploitative practices in health 
research have resulted in a proliferation of ethics guidelines to ensure the ethical conduct of health 
research over the past half century. These include the Nuremberg Code (1947), the various 
iterations of the Declaration of Helsinki (most recently in 2013), and the Council for International 
Organisations of Medical Sciences (CIOMS) Guidelines (most recently revised in 2016).  
 
The CIOMS (2016) ethics guidelines for humans in health research call for ‘community engagement’ 
in health-related research. They state: 
Researchers, sponsors, health authorities and relevant institutions should engage potential 
participants and communities in a meaningful participatory process that involves them in an 
early and sustained manner in the design, development, implementation, design of the 
informed consent process and monitoring of research, and in the dissemination of its results. 
(CIOMS, 2016, p. 25) 
‘Community’ is defined broadly by these guidelines, as various sectors of society that may have a 
stake in research. The CIOMS guidelines (2016) also advise that gatekeeper permission should be 
sought if considered necessary, prior to the conduct of a clinical trial. Such permission would be 
necessary if the trial “substantially affects …. organisational interests” and if there is an identifiable 
gatekeeper (who may be an individual or a committee or council of some kind) who has the 
“legitimate authority” to make decisions on behalf of the organisation or community (p. 80).  
 
2.3  HEALTH RESEARCH IN SOUTH AFRICA 
 
Health research is a vital component of health and health care in South Africa. The most outstanding 
example of how health research has benefitted South Africans is that of HIV research, where 
treatment modalities have been developed that have transformed a disease that was a death 
sentence two decades ago to a chronic disease that can be managed at a primary care level 
(Antiretroviral Therapy Cohort Collaboration, 2017). The centrality of health research to the field of 
health care is acknowledged by the current National Minister of Health, Dr Aaron Motsoaledi, in his 
foreword to the revised ‘Ethics in Health Research: Principles, Processes and Structures’ (NDoH, 
2015).  
 
South Africa is highly active in health research, both in the private and the public sector (Paruk, 
Blackburn, Friedman, & Mayosi, 2014). Between 1991/2 and 2009/10, government expenditure on 
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health research rose from 1.9% of GERD1 to 3.5% (Paruk et al., 2014). Much of this health research 
takes place in public health facilities, especially research on diseases such as HIV and tuberculosis, 
which affect mainly the poorer parts of the population, who depend on the public sector for their 
health care (Keeton, 2010).  
 
In South Africa, there are several factors that may undermine the establishment of equitable 
relations between health researchers and key stakeholders. These include its colonial and Apartheid 
history of racial exploitation including in research (Baldwin-Ragaven, London, & De Gruchy., 1999); 
therefore the potential for research to be, or at least to be perceived as, exploitative, is perhaps 
higher in South Africa than in many other countries. In addition, the profound income inequality in 
South Africa (Leibbrandt et al., 2010) may exacerbate the existing imbalances of power in research 
relationships, where researchers may already be perceived to be part of a social elite (Benatar 2002; 
Christakis, 1992). In post-Apartheid South Africa, many sectors of society continue to experience 
marginalisation and exclusion (Netshitenzhe, 2013). There is also the inherent imbalance of power 
between the researcher, who has by definition vast knowledge about his/her subject, and the 
research participant, who almost always has less (Benatar, 1998).  
 
Thus in South Africa, this imbalance of power, real or perceived, may extend to the relationship 
between researchers, and the health managers (and staff) of government facilities where much 
health research takes place. These health managers arguably have crucial roles to play in the 
research process, from conception of study questions (where they might provide valuable insight 
into the most current and relevant issues facing health and health service delivery), to providing 
access to health facilities, patients and data (their ‘gatekeeper’ role), to the conduct of research 
(where they might facilitate the smooth implementation of research projects), to the utilisation of 
research results (where they might be instrumental in using results to inform health policies and 
protocols, and improve service delivery). The interaction between researchers and health managers 
therefore may have an impact on all of these stages in the research process. 
 
2.4  ETHICAL-LEGAL FRAMEWORK FOR HEALTH RESEARCH IN SOUTH AFRICA 
 
In South Africa, health research is governed by the National Health Act (no. 61 of 2003) (Republic of 
South Africa, 2004). This defines health research as any research: 
                                                          
1 GERD is the “gross expenditure on research and development”.  
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which contributes to knowledge of (a) the biological, clinical, psychological or social 
processes in human beings; (b) improved methods for the provision of health services; (c) 
human pathology; (d) the causes of disease; (e) the effects of the environment on the 
human body; (f) the development or new application of pharmaceuticals, medicines, and (g) 
the development of new applications of health technology. (Republic of South Africa, 2004, 
p. 12).  
According to the NHA (Republic of South Africa, 2004), all health research must be reviewed by a 
REC registered with the NHREC.  
 
In KwaZulu-Natal, the province in which this study was conducted, health research is further 
governed by the KwaZulu-Natal Health Act (no. 1 of 2009). This Act provides for the establishment of 
the KwaZulu-Natal Provincial Health Research and Ethics Committee (KZN PHREC) and for the 
composition of the Committee, which must include representatives from the Department of Health 
as well as from research and academic organisations. The KwaZulu-Natal Health Act outlines the 
responsibilities of the Committee, which include setting health research priorities for KZN, reviewing 
and if appropriate approving proposals for research conducted in provincial health facilities (or with 
patients recruited from these facilities), reviewing research reports and ensuring that the research 
conducted “promotes health, contribute(s) to the prevention of communicable or non-
communicable diseases or disability or result(s) in cures for communicable or non-communicable 
diseases” (p. 18). The regulations to the KwaZulu-Natal Health Act further provide, inter alia, for the 
review of applications to conduct clinical trials in provincial health facilities by the Pharmaceutical 
Services component of the KZN Department of Health (Section 12.4.(c)). 
 
The KZN PHREC does not review each research application as a committee, but delegates the 
authority to approve observational research to the Chair of the committee, provided that 
applications have the support of the facility, district or programme manager concerned (the first 
level ‘gatekeeper’) as evidenced in a letter of support, as well as provisional REC approval. Once all 
these documents have been received in good order, the KZN PHREC issues a letter of permission to 
the researcher, thus acting as a second level ‘gatekeeper’ in the process. The researcher then sends 
this letter back to the REC concerned, upon receipt of which the REC issues the letter of final 
approval. The process for clinical trials is slightly different; due to their more complex nature, clinical 
trials are required to be approved by the Head of the KZN Department of Health and, in addition to 
the facility support letter, undergo review by relevant managers within the KZN Department of 
Health (KZN DoH, 2017). All research applications must be loaded onto the National Health Research 
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Database, which was established by the SA National Department of Health in 2014 and is managed 
on its behalf by the Health Systems Trust.  
 
The conduct of all health research in South Africa is also governed by the National Department of 
Health’s ‘Ethics in research: principles, processes, structures’ (NDoH, 2015). These ethics guidelines 
assert that “role player engagement” (NDoH, 2015, p. 16) is a key ethical norm and standard. These 
guidelines assert that: 
researchers should engage key role players at various stages of planning and conducting 
research to improve the quality and rigour of the research, to increase its acceptability to 
the key role players, to harness role player expertise where possible, and to offset power 
differentials where these exist. Engagement efforts may comprise of various activities, 
including awareness-raising initiatives for role players, including but not limited to 
participating communities. (NDoH, 2015, p. 16)  
 
The main aim of these documents is the protection of participants in health research projects, and 
they outline key norms and standards in order to achieve this aim. However, despite 
recommendations in national ethics guidance, the research process is arguably also affected by the 
‘ethos’ of health research, “that is, the visions and projects that orientate and direct the discourses 
and practices of different actors and groups, in different places, situations and periods” (Geissler 
2011, p. 3). The ethos of health research is shaped by context, which in turn depends on historical, 
political, economic and sociological influences (Geissler 2011). Thus in spite of numerous 
international and local guidelines, and pieces of legislation governing the ethical conduct of 
research, the process of conducting research might be dependent at least in part on the perceptions 
and practices of stakeholders in the research process, and the relationships between them.  
 
2.5 RELATIONSHIPS BETWEEN RESEARCHERS AND MANAGERS OF HEALTH FACILITIES OR 
PROGRAMMES 
 
Researchers and managers of public health facilities make direct contact at several stages of the 
research process. At each stage, their attitudes or perceptions may affect the quality of the 
relationship between them, and thus may impact on the success or otherwise of the research itself. 
Frequently, the first of these contacts is at the time when researchers apply for permission to access 




In KwaZulu-Natal, this permission is provided by the manager of the facility, district or programme in 
their capacity as ‘gatekeeper’. ‘Gatekeepers’ in the context of research can be defined as 
“authorised signatories of the institution that hosts the intended research participants” (Singh & 
Wassenaar, 2016, p. 42). The right of gatekeepers to allow or refuse the conduct of research in their 
facilities is recognised by South African RECs (Singh & Wassenaar, 2016). For example, the 
Biomedical Research Ethics Committee of the University of KwaZulu-Natal (BREC) does not generally 
issue full ethics approval for research projects until permission has been received from the KZN 
PHREC (Singh & Wassenaar, 2016). Similarly, the KZN PHREC itself does not issue its letter of 
permission without the facility manager’s letter of support (KZN DoH, 2017). The relationship 
between health managers and researchers may influence health managers’ willingness to provide 
approval and subsequent access to the site, and such relationships are therefore likely to be vital for 
the conduct of research.  
 
2.6  RELATIONSHIPS BETWEEN RESEARCHERS AND HEALTH MANAGERS AS ‘GATEKEEPERS’ 
 
The relationship between health researchers and managers of health facilities as ‘gatekeepers’ has 
been somewhat neglected in the stakeholder engagement literature, both internationally and in 
South Africa. Much has been written about how participating communities, from which research 
participants are drawn, should be engaged by researchers, their capacity built, their concerns 
addressed and how they should negotiate research-related benefits with funders and researchers 
(Folayan et al., 2015; Kamuya et al., 2014; King, Kolopack, Merritt, & Lavery, 2014; Koen, Essack, 
Slack, Lindegger, & Newman, 2013; Musesengwa et al., 2017; Musesengwa & Chimbari, 2016; 
Tindana et al., 2007). There is also an increasing body of literature where researchers are publishing 
their approach to stakeholder engagement; notably, the engagement of community stakeholders 
around research projects is described as being more difficult and complex than is commonly 
depicted in the engagement literature (Kolopack, Parsons, & Lavery, 2015).  
 
Similarly, guidance exists on the role of RECs in the research process, and how these can provide 
oversight of the research itself (Kruger, Ndebele, & Horn, 2014: UK Research Integrity Office, 2008) 
and how research teams should carefully engage RECs as a key stakeholder in their research 
(Wassenaar & Rattani, 2016). However, the relationship between (and respective perceptions of) 
researchers and health managers as ‘gate-keepers’ appears less frequently in the literature around 
health research. This is an important gap in efforts to achieve the collaborative partnerships in 




As stated above, the relationships between researchers and ‘gatekeepers’, and the relevant 
attitudes, have received some attention in the health research literature, but more in the areas of 
social work and education research. In several such papers, authors emphasise that negotiating 
access through ‘gatekeepers’ can be a complex and difficult process. One author even titled her 
research methods case study ‘Gatekeepers: People who can (and do) stop your research in its tracks’ 
(Ahern, 2014). Other authors describe their encounters with ‘gatekeepers’ as emotional and difficult 
(Peticca-Harris, de Gama, & Elias, 2016), and the researcher-gatekeeper relationship as unstable and 
inconsistent (Sanghera & Thapar-Bjorkert, 2008).  
 
Several authors do suggest ways in which their relationships with ‘gatekeepers’ can become less 
fraught and their engagements more productive. For example, in the field of social work research, 
one study investigated researchers’ perceptions of gatekeepers’ motivations in the United Kingdom 
(Clark, 2011). Their study aimed to explore, through in-depth interviews, researchers’ perceptions of 
the motivations of social workers, acting as ‘gatekeepers’, to engage with the research process. It 
found that ‘gatekeepers’ were more likely to engage with researchers if they felt that their views 
were appropriately represented, if they felt that they had a moral responsibility to engage, and if 
they felt that the research project itself would be useful to them. Another study explored the 
relationship between ‘gatekeepers’ and socially excluded communities, living in a low income 
housing estate in the north of England (Emmel, Hughes, Greenhalgh, & Sales, 2007). This study 
looked at ways in which 'gatekeepers’ might facilitate or impede the access of researchers to socially 
excluded communities. It found that trust between ‘gatekeepers’ and the communities they 
‘protected’ was a central issue in negotiating access by researchers to these communities.  
 
A study in the field of health care (regarding obtaining access to staff and facilities for a primary 
study on safety in surgical operations) found that ‘gatekeepers’ (managers of the facility) may act as 
champions of the research project if they perceive that the research is important for the institution 
(Høyland, Hollund, & Olsen, 2015). In addition, there are several studies that comment on the 
‘gatekeeper’ role, even though the stakeholders described are not explicitly labelled as such. For 
example, a paper describing the events around stoppage of the Tenofovir trial in Cambodia by the 
then Prime Minister Hun Sen, illustrated the importance of regular, effective and transparent 
communication with national government authorities around research projects (Upkong & Peterson, 
2009). This paper illustrated that national government gatekeepers may find it necessary to block or 




In order to ensure that ethical and scientifically sound research takes place, healthcare authorities 
should be active and equal participants in the discussions around research, and its implementation 
and uptake (UNAIDS/AVAC, 2011). There is no empirical research investigating the relationships 
between researchers and health managers as ‘gatekeepers’ in public health facilities, in KwaZulu-
Natal.  
 
2.7 RELATIONSHIPS BETWEEN RESEARCHERS AND HEALTH MANAGERS AT LATER STAGES OF 
RESEARCH  
 
Health managers do not only act as ‘gatekeepers’ by providing their approval for researchers to 
access sites for research participants. Once access to a health facility has been obtained, researchers 
and health managers may come into frequent, almost constant contact whilst the research is being 
conducted. Importantly, researchers and health managers also make contact at the stage of 
dissemination and utilisation of research results. Although authors acknowledge that, even in high-
income countries, research results are often “imperfectly incorporated” into practice, they also 
emphasise the importance of this stage (Emanuel et al., 2004). Unless research results are made 
known to service providers and policy makers, creating opportunities to put the results into practice, 
the impact of research on health service delivery and on health itself may never be realised, 
rendering futile the investments that the research process entails. The importance of this stage in 
the research process is widely recognised and a myriad of tools have been developed to facilitate it 
(Wilson, Petticrew, Calnan, & Nazareth, 2010). Indeed, this stage of the research process has 
developed into a distinct entity (‘knowledge translation’) which has generated a vast body of 
literature and research (Armstrong, Waters, Roberts, Oliver, & Popay, 2006; Davis et al., 2003; 
Grimshaw, Eccles, Lavis, Hill, Squires, 2012; Oborn, Barrett, & Racko, 2010). However, in spite of this, 
commentators have argued that it remains poorly done in South Africa (Senkubuge & Mayosi 2013).  
 
The relationship between researchers, managers and policy makers in the final stage of the research 
process (the knowledge translation stage) has been discussed by some authors, albeit seldom 
through empirical research. Armstrong et al. (2006) explored the theoretical foundations of how 
knowledge is translated into action, and proposed six models that describe varying degrees of 
involvement of policy makers and managers in knowledge production. They emphasised that 
knowledge is best used to inform policies and practice when policy makers and planners are directly 
involved in research, from the development of the research question, to the incorporation of results 
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into policy and practice. Ward et al. (2010) developed guidelines for stakeholders in the United 
Kingdom around the translation of knowledge into action, and emphasised the importance of 
context, and individual beliefs and attitudes, in the process.  
 
A study conducted in Kenya, explored the views of health policy makers and implementers (several 
of whom would also meet the definition of ‘gatekeepers’) on what type of research should be 
conducted, and how the benefits of such research should be used by stakeholders (Lairumbi et al., 
2008). In- depth interviews were conducted with stakeholders, using two case studies as the basis 
for discussions. The study found that government officials felt that they had little power in 
determining the research agenda, were often excluded from discussions around the research, 
including at the dissemination stage, and because of these factors, found it difficult to use the 
research results to influence policy and practice (Lairumbi et al., 2008). Aside from this study, there 
appears to be little empirical research on the relationship between public health facility 
stakeholders, and researchers themselves, and the perceptions and practices of these two groups, in 
low-resource settings. This lack of data may undermine efforts to improve relationships and to 
address the causes of negative perceptions where these exist.  
 
2.8  SUMMARY 
 
In summary, health research is necessary to make advances in understanding of disease aetiology 
and processes, the development of treatments and of ways to deliver these treatments. Health 
research is a complex field involving a wide range of actors with diverse interests and priorities 
(UNAIDS/AVAC, 2011). In order for the smooth conduct of research and for research results to be 
accepted and utilised, it is important that the relationships between research stakeholders are 
collaborative. Recent international ethical guidelines (CIOMS, 2016; UNAIDS/AVAC, 2011) and 
national ethical guidelines (NDoH, 2015) increasingly call for researchers to pro-actively engage key 
stakeholders in order to enhance the rigor of the research. There is an increasing amount of 
literature exploring how health researchers engage representatives of the participating-community 
(Kolopack et al., 2015). There has been less empirical research exploring the relationship between 
researchers and health managers who control access to potential health research participants, and 
who might use the results of health research. It is important that the perceptions and practices of 
researchers, and the managers of public health facilities and programmes in South Africa, be 
explored, in order to facilitate sound research in such settings. This study attempts to begin this 
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process by exploring perceptions and practices of these two stakeholders in public health facilities in 





STUDY AIMS AND METHODOLOGY 
 
This chapter outlines the study aims, the methods used and the paradigm in which the study was 
located. Ethical considerations are also set out. 
 
3.1  STUDY AIMS 
 
The major objective of this study was to explore the perceptions of key stakeholders regarding 
health research conducted in in public health facilities in the province of KZN, in order to improve 
the conduct of research and utilisation of research results in KZN. Specific aims were: 
1. To explore the perceptions and practices of key stakeholders related to research 
conducted in provincial public health facilities, including processes around its planning, 
approval, conduct, dissemination and impact 
2. To explore the perceptions and practices of key stakeholders regarding inter-stakeholder 
relations  
3. To make recommendations to strengthen the ethical conduct of such research, including 
implementation and uptake of research results, and inter-stakeholder relations  
 
3.2  STUDY APPROACH 
 
3.2.1 QUALITATIVE STUDY DESIGN 
 
A qualitative approach was chosen for this study because qualitative methods enable the 
description, exploration and explanation of phenomena being studied (Ploeg 1999); this was 
therefore considered the most appropriate approach to obtain the in-depth data required to answer 
the study aims. This study was broadly located in an interpretivist perspective, which focuses on 
practices, subjective meanings that are attached to practices, and the context in which these 









Qualitative researchers are encouraged, as part of a commitment to reflexivity, to describe their 
training (Malterud, 2004), their personal and professional experiences of the subject matter 
(Malterud, 1993), and any pre-conceptions or initial beliefs about the subject matter (Elliot, 1999). I 
joined the KwaZulu-Natal Department of Health in 2011 as Manager of the Epidemiology, Health 
Research and Knowledge Management Units, and was nominated by the then Head of Department 
to establish and chair the KwaZulu-Natal Health Research and Ethics Committee (KZN PHREC) (which 
is responsible for providing approval for the conduct of research in provincial public health facilities).  
 
By virtue of these positions, I had encountered (anecdotally) competing views on ethics and research 
ethics, which I needed to understand and manage. There seemed to be significant tensions in the 
relationships between stakeholders of health research in the province, specifically between 
researchers, and the managers of public health facilities and health programmes. On the one hand, 
these managers had voiced their concerns that researchers seldom engage with them on the 
research they are conducting in ‘their’ health facilities, including in giving them feedback on research 
results. On the other hand, researchers had complained about the lengthy and onerous research 
application process, particularly the process of applying to conduct clinical trials. I was of the view 
that, while there was some understanding of the broad concerns, a much more detailed 
understanding was required of the perspectives of these two stakeholder groups, in order to 
facilitate a more productive research process for those concerned.  
 
I have some experience with conducting research myself, namely through a Masters in Public Health 
(Lutge & Muirhead 2005), a Fellowship in Public Health and a PhD in Epidemiology (Lutge, Lewin, & 
Volmink, 2014; Lutge, Lewin, Volmink, Friedman, & Lombard, 2013). Whilst most of this research 
was quantitative, the PhD included some qualitative components that were central to the study 
(Lutge et al., 2014). My PhD examined the effect of a material incentive on the adherence of patients 
with TB to their treatment. The qualitative components explored the perceptions of facility 
managers, programme managers and patients regarding the incentive – the practicalities of how it 
was administered and utilised, and the more philosophical arguments around the merits of ‘paying 
people’ to behave in a healthy way. Incidentally, I followed the same application process to obtain 




I also manage two Department of Health units (Research and Epidemiology). The Research unit acts 
as the secretariat for the Provincial Health Research and Ethics Committee, providing the final 
permission from the Department of Health for researchers to access health facilities to collect data. 
Therefore, I had some experiences that resonated with the views expressed anecdotally by both 
groups of stakeholders. However, I was concerned that neither of these groups seemed willing to 
spend the time or make the effort to understand the other party, and I was of the view that a 
detailed exploration might shed light on their perspectives. I was aware of my strongly held belief 
that research is crucially important for health and development in South Africa, and in the province. I 
also knew I would need to be cautious that I did not favour the viewpoints and imperatives of 
researchers over those of health managers. Whilst conducting this study I attempted to be open to 




Interviewees were selected purposively, that is, participants whom it was thought would provide 
rich and relevant information for the study, were approached preferentially to participate (Gentles, 
Charles, Ploeg, & McKibbon, 1999). Managers from health facilities where research was regularly 
and recently hosted were invited to participate. Also, currently active researchers, who were 
employees of the KZN Department of Health, as well as those who worked in organisations external 
to the Department, were invited to participate. Snowball sampling (defined as the identification of 
new participants through existing participants) (Atkinson & Flint 2001) was not used; and was not 
necessary to secure adequate enrolment. 
 
Eighteen interviews in total were conducted – eight with health managers, and ten with researchers. 
There was only one refusal to participate; the person expressed concerns about time constraints.  
 
3.2.4 DATA COLLECTION 
 
Instrument: A semi-structured interview schedule was used for data collection. There were outlines 
of the major domains that should be covered in the interviews, but allowance was made for the 
interviewer to probe issues raised by respondents, and to explore issues considered to be important 
and relevant to the study (Britten, 1995). After conducting interviews with two interviewees (one 
health manager and one researcher), the interview schedule was very slightly modified (Tong et al. 
2007). That is, more prompts were added on issues around the conceptualisation of the research 
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question, because this was identified by one interviewee (a health manager) as a significant deficit. 
Also more prompts were added on the accessibility of health managers to discuss issues around 
research, because this was identified by another interviewee (a researcher) as a major deficit. These 
minor modifications to the prompts did not alter the scope of the ethically approved study, and 
were in line with the iterative nature of qualitative research (DiCicco-Bloom & Crabtree, 2006). 
 
The domains of the interview schedule included the following: 
• Demographic and background information such as their role in organisation and their 
experience with research 
• Views around the importance of research, both generally and for KZN in particular 
• Perceptions around the benefits of research 
• Perceptions on their relationships with researchers or health managers (depending on their 
own positions) at various stages in the research process  
• Factors perceived to undermine research 
• Factors perceived to facilitate research 
• Factors perceived to affect the relationship between health managers and researchers. 
• Recommendations for how research could be improved 
• Recommendations for how relations could be strengthened. 
 
Procedure:  The principal investigator telephoned potential participants in order to explain the study 
and invite them to participate. If there was interest, the principal investigator emailed them the 
study informed consent form and information sheet (see Appendix 1), as well as a sample of the 
interview guide (see Appendix 2 and 3), and an offer to discuss any aspect of the study with them. 
After potential participants had emailed their interest in participating, a time and place for the 
interview was scheduled. Interviews usually took place in the participants’ own offices. Upon 
meeting, the study was explained again to each participant, and an opportunity given to them to re-
read the informed consent form and information sheet, to ask questions and to clarify areas that 
were not clear (Turner, 2010). This was considered important given empirical data that time in 
discussion is a useful method for enhancing participants’ understanding of a study (Flory & Emanuel, 
2004). Participants were also asked if they would give permission for the interview to be audio-
recorded. On agreement, the informed consent form, giving consent for both the interview and the 
recording, was signed. Only one participant refused permission for the recording, and in this case 




All interviews were face to face and conducted by the principal investigator. All interviews were 
transcribed verbatim by a study transcriber, assisted by the principal investigator. Transcripts of 
interviews were analysed on an ongoing basis, during data collection, so that points of importance 
that should be explored in further interviews, and the point of data saturation could be identified 
(Thorne, 2000). When no new themes were being identified (i.e. when data saturation had been 
reached) (Guest, Bunce, & Johnson, 2006) the researcher stopped approaching potential participants 
for interviews.  
 
3.2.5 DATA ANALYSIS 
 
Thematic analysis was undertaken in this study. Thematic analysis has been defined as a “method for 
identifying, analysing and reporting patterns within data” (Boyatzis, 1998, in Braun & Clarke, 2006, p. 
79). It supported the interpretivist approach adopted (Braun & Clarke, 2006), and was feasible for 
the principal investigator who was relatively new to qualitative research and was able to build on the 
“core skills” of qualitative research through this methodology (Braun & Clarke, 2006, p. 4).  
 
Thematic analysis involved the following steps:  
 
Firstly, segments of text that encapsulated points or issues relevant to the study aims were coded, 
i.e. assigned a phrase that reflected their meaning and relevance to the study. Coding was both 
deductive, in that codes were developed ‘a priori’ based on the literature, such as the Good 
Participatory Practice Guidelines for Biomedical HIV prevention trials (UNAIDS/AVAC, 2011), and 
inductive, in that they emerged from engagement with the transcripts (Stuckey, 2015). For example, 
the phrase ‘Unfortunately patients involved in clinical research get better care than patients [who] 
aren’t’ was assigned the code ‘Better care: superior to usual care’.  
 
Secondly, codes, together with their illustrative fragments of text, were grouped together in code 
clusters or sub-themes (Green et al., 2007). Here, codes that shared a relationship were grouped 
into coherent clusters (Green et al., 2007). For example, the code ‘Better care: superior to usual care’ 
was grouped with other similar codes into the sub-theme ‘Value for enrolled participants’, which in 
turn was grouped into a main or master theme entitled ‘Varying perceptions of ‘social value’.  
 
Thirdly, theme tables were used to organise master themes, which contained various sub-themes, 
which in turn contained ‘related’ codes grouped into these sub-themes, as well as data extracts for 
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each code with interviewee identifiers. Fourthly, a narrative was drafted from each master theme 
table. These narratives formed the basis of the results reported in this study. The themes were 
described in the results, where more detail was given on the meaning of each theme, and illustrated 
by the text fragments (data) that supported the construction of the themes. Individual themes were 
described, using sub-themes to give explanatory detail, and the connections between themes were 
also described (Braun & Clarke, 2006).  
 
The list of codes is attached as Appendix 4.  
 
3.3  STUDY QUALITY 
 
Due to the flexible nature of qualitative research, the application of a single set of criteria to ensure 
quality may be difficult (de la Cuesta Benjume, 2015). However, a stronger and more universally 
accepted set of criteria has been developing over the past few decade (Cameron, 2011). Whilst the 
term ‘rigor’ is often used to describe the quality of quantitative research, the term ‘trustworthiness’ 
is generally preferred when describing the quality of qualitative research (Cameron 2011). In order 
to ensure the trustworthiness of qualitative research, four criteria have been outlined (Cameron 
2011; Shenton, 2004). These are: credibility (are the study findings a sound representation of 
participants’ responses?); transferability (can the findings of the study be applied in other settings?); 
dependability (if the study were undertaken in the same context with the same participants, would 
similar results be obtained?) and confirmability (do the results of the study reflect the perspectives 
of the participants, as opposed to those of the researcher?) (Cameron 2011; Shenton 2004). Efforts 




Well established research methods were used in this study (Braun & Clarke 2006). In-depth 
interviews, analysed through Thematic Analysis, are well described methodologies in the field of 
qualitative research and there are many guiding documents which assist the researcher in applying 
these methods (Aronson, 1995; Boyatzis 1998; Braun & Clarke, 2006; Gentles et al., 2015; Green et 
al., 2007; Guest et al., 2006, Ploeg 1999; Shenton 2004). The researcher had some experience in 
conducting qualitative research as a sub-component of her PhD. Also, several transcripts were coded 
independently by both the principal investigator and the supervisor. Because inter-rater reliability 
checks are not considered appropriate for the interpretivist approach (Yardley, 2008), coding 
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differences were resolved by discussion (Boyatzis, 1998). The codes so developed were used as the 
basis for coding later transcripts.  
 
Furthermore, it was in no way communicated to participants that they would be ‘worse off’ if they 
did not participate in this study (which would have been coercive) (Emanuel et al., 2004). 
Participants were assured of anonymity, to increase the likelihood they would be sincere and honest 
in their interviews, with less social desirability (Lindegger & Richter, 2000). Questions were re-
phrased in the interviews, and clarity requested when necessary, in order to ensure that the 
information given by participants was correctly understood by the researcher.  
 
In addition, the researcher (who also conducted the interviews) reflected on her own role in the 
study throughout, and the effect of her personal experience on the conduct of the interviews and 
the interpretation of the data, in an effort to improve the quality of the research (Palaganas, 
Sanchez, Molintas, & Caricativo., 2017). Also, views that were opposite to those generally expressed 
in the interviews were highlighted to ensure that they added depth and value to the analysis (Tong 
et al., 2007). For example, the following quote from a researcher was directly opposite to what most 
health managers felt, ‘..so there is no way it (research) detracts (from service delivery). It… definitely 
makes health care better…’ 
 
Lastly, the results of the other studies in the field were examined and it was found that the results of 
this study resonated with these (notwithstanding the fact that many of these were in fields other 
than health) (Campbell et al., 2006; Clark 2011; Høyland et al., 2015).  
 
3.3.2 TRANSFERABILITY, DEPENDABILITY AND CONFIRMABILITY 
 
Although transferability is not the main aim of qualitative research, it is useful to reflect on the 
extent to which the study findings might be applicable in other contexts (Shenton, 2004). The 
sample and methodology of the study have been described in sufficient detail (in Chapter 4) for 
others to judge their utility in other contexts (Green et al., 2007). It is possible that these findings 
might be useful in other settings that share similarities, such as in other provinces in South Africa. All 
other provinces have provincial health research committees, which provide final approval for 
researchers to conduct their research in public health facilities. Because the context of many of 
these provinces is similar to KZN, it is likely that some of the findings of this study will be useful in 




Also, interviewees were drawn from a variety of research organisations and public health facilities in 
the province, thus ensuring a range of perspectives and views were canvassed (Braun & Clarke, 
2006). The data collection methods used were well known and well described, and responsibly 
applied in this study (Gill, Stewart, Treasure, & Chadwick, 2008). Data was collected over the period 
of a year, aiming for representivity over time as well as over a number of organisations (Shenton, 
2004). 
 
Efforts to ensure credibility also tend to support dependability in a study (Shenton, 2004), but in 
addition a clear description of the design and methods of the study, as well as a reflection on the 
researcher’s own role in generating the results of the study, are presented in this chapter. In terms 
of confirmability, the researcher has made efforts to identify and articulate her own prior 
experiences, and pre-existing ideas, and the effect of this on the analysis and interpretation of the 
data, throughout this study (de la Cuesta Benjume, 2015).  
 
3.4  ETHICAL CONSIDERATIONS 
 
According to the National Health Act (Republic of South Africa, 2004), all health research in South 
Africa must be approved by an REC registered with the NHREC. This study was approved by the 
Biomedical Research Ethics Committee of the University of KwaZulu-Natal (reference: BE346/16). 
Permission to conduct the study was also given by the KwaZulu-Natal Department of Health 
(reference HRKM333/14) (see Appendices 5, and 6 respectively).   
 
Anonymity: No names were recorded in this study, and no individuals nor individual research 
organisations, or health facilities were identifiable. In terms of storage of data, all data (hard copies 
of transcripts as well as electronic copies of transcripts and electronic recordings of interviews) were 
stored safely in locked drawers in the office of the principal investigator, and on the password-
protected computer of the principal investigator.  
 
A potential conflict of interest was managed in the following way: Because the principal investigator 
is involved in the approval of health research projects conducted in provincial health facilities or 
involving patients of the provincial Department of Health, this issue was discussed with potential 
interviewees, who were assured that their refusal to take part would not jeopardise the approval of 
their research proposals, and interviewees were assured that any views they expressed would not 
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affect their research proposals. The researcher was also alert to the potential for interviewees to 
express socially desirable views (Collins., Shattell & Thomas, 2005). In order to reduce social 
desirability bias, the principal investigator requested participants before the interviews to give 
honest answers; to enhance the likelihood that the results of this study might be used to improve 
the research process in KZN. 
 
In terms of informed consent, the study was discussed with potential interviewees (who were given 
opportunity to ask questions and raise concerns) so that their understanding of the study could be 
ensured (CIOMS, 2016, Guideline 9; Declaration of Helsinki, 2013, articles 25 to 32). Once ‘enrolled’, 
interviewees were able to ‘opt out’ of answering questions if they so wished. In terms of payment, 
participants were not paid for their expenses because they did not incur any expenses. They were 
also not paid for their time, and this approach to payment was approved by the REC (National Health 
Research Ethics Council, 2012). 
 
Feedback on preliminary results to stakeholders has already been given, through the Research Day 
held by the KZN Department of Health in 2016, which was attended by managers in the Department 
and researchers working in the province. Feedback to stakeholders in the future will also be given, 
by posting summaries of the study onto the web page of the Health Research and Knowledge 
Management Unit of the KZN Department of Health, and using them as a basis for discussion at the 
next provincial research prioritisation meetings (due to take place in 2018).  Feedback to individual 
interviewees will be provided by emailing summaries of the study to them and discussing these in 
person if so desired.  
 
3.5  STUDY LIMITATIONS 
 
Participation of health managers in this study was confined to middle and lower managers within the 
KZN Department of Health. The highest rank of manager invited to participate was the Director level. 
That is, higher-level managers (e.g. Chief Directors, Deputy Directors General) were not invited to 
participate. This sample selection was intentional. Only managers who had direct involvement with 
researchers at their health facilities or in their programmes, and who played prominent 
‘gatekeeping’ roles in the researcher-health manager relationship, were invited to participate. More 
senior managers who do not play the role of ‘gatekeeper’ were omitted from this study. However, 
because the latter do play an important role in translating research findings into policy and practice, 
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the omission of more senior managers may have diminished the richness of data on the latter phase 
of research, as well as the breadth and variety of views obtained for this study.  
 
Similarly, health workers at operational level were not invited to participate. Although again this 
omission was intentional, it may have resulted in loss of detail around relations between researchers 
and health workers ‘on the ground’.  
 
Similarly, researchers who were active in conducting research at KZN Department of Health facilities 
were invited to participate. More senior members of research organisations (such as Directors and 
Chief Executive Officers) were not invited. Again, this may have resulted in the loss of important 
viewpoints which may either have reinforced the views of those selected, or added a variety of 
divergent views. In addition, members of the PHREC involved in the approval of research conducted 
in provincial health facilities were not sampled. As an important level of gatekeepers in KZN health 
research, this would be a useful addition to the sample in future research.  
 
Although interviewees were asked to give honest views, and not to be constrained by the fact that 
the principal investigator was also the manager of the Research Unit at the KZN Department of 
Health, it is possible that they refrained from making critical comments that referred directly to the 
principal investigator herself, confining themselves to more general issues, or issues not relating 
directly to the principal investigator.  
 
A further limitation is that document analysis (Bowen, 2009) was not conducted for the purposes of 
this study. Documents such as the operational guidelines of the KZN Provincial Health Research and 
Ethics Committee (KZN DoH, 2017), and even minutes of meetings of the KZN PHREC, may have 
yielded new codes not captured in the interviews, and generated new insights into the issues being 
explored.  
 
Finally, respondents were not given the transcripts of their interviews for review, in order to confirm 
that the transcripts were a true reflection of their perceptions. This approach was not adopted and 







In this chapter, the sample is briefly described and the results of the study are reported. The results 
are structured according to the dominant or ‘master’ themes that emerged, informed by several 
minor or sub-ordinate themes.  
 
4.1 SAMPLE CHARACTERISTICS 
 
Eighteen (18) participants agreed to take part in this study. All but one respondent agreed to their 
interview being tape recorded and for the one respondent who refused, detailed notes were taken 
of the interview and used in the analysis. Eight (44%) of participants were managers of hospitals or 
health care programmes within the KwaZulu-Natal Provincial Department of Health. Seven (39%) 
were researchers employed by independent research organisations or by academic institutions. 
Three (17%) were physicians employed by the KwaZulu-Natal Provincial Department of Health who 
were active in the field of health research and had conducted research within the year prior to this 
study. Eight (44%) of the participants were female and all participants were between the ages of 40 
and 67 years.  
 
All researchers and physicians were currently active in research in KZN and had conducted research 
projects in public health facilities in the province within the year prior to the study. The institutions 
from which they were drawn varied from large ones, with strong national and global reputations, to 
small and lesser known organisations. All managers were drawn from research-active health facilities 
or programmes and had acted as ‘gate-keepers’ for researchers to access participants or their data 
in the year prior to the study. The ‘gate-keeping’ function entailed providing researchers with letters 
of support, confirming that they were willing to host the research in their institutions or 
programmes. This letter of support would be forwarded to the KZN PHREC, together with the 
research protocol and letter of provisional ethics approval. If all documents were in order, the study 
would then be given final permission by the PHREC.  
 
Results are presented according to the three major themes which emerged from the analysis of 
interview data about research in public health facilities in KwaZulu-Natal. These are: 
1. Varying perceptions of ‘social value’  
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2. Strained inter-stakeholder relations  
3. Strengthening research and relations.  
 
Because this was an exploratory qualitative study, the exact number of interviewees holding a 
certain view was generally not reported (Marshall, 1996); instead, the reporting convention of 
‘some’, ‘many’, ‘most’ or ‘all’ was generally used. Quotes from the interview transcripts are given 
verbatim. The notation ‘ …. ‘ has been used to show pauses in the interviewees’ speech, and (…) has 
been used to show where words from the transcript were omitted. Where inserting a word helped 
to make sense of the quote, inserted words are given in square brackets [].  
 
4.2 THEME 1: VARYING PERCEPTIONS OF SOCIAL VALUE 
 
This major theme sets out how researchers and health managers perceived the value of research 
differently. This theme emerged as critically important during the analysis, not only as an 
‘independent’ theme which conveys the varying perceptions of interviewees around the value of 
research in KZN, but also as one that had an important impact on the other major themes; that is, 
differing perceptions of the social value of research may have impacted on the perceived quality of 
inter-stakeholder relationships (Theme 2), and enhancing the perceived social value of the research 
for those involved was perceived as an important step towards improving stakeholder relations and 
enhancing the research process in KZN (Theme 3).  
 
All interviewees perceived that health research in KZN did have social value – that is, that it was 
inherently important and had the potential to improve health and health care, as this researcher and 
health manager say: 
[Health research is] extremely important. I think it makes [a] massive difference to public 
health. (Interview 2; Physician researcher).  
 
We have benefitted directly as a province. Clinical outcomes have improved as a result of 
research – these improvements we can prove are as a result of research. (Interview 6; Health 
manager)  
 
However, interviewees varied in their perceptions of what it was that made research valuable, and 
therefore for whom the research was valuable, and this variation tended to correspond with their 
roles in the research process. That is, the elements of research perceived as most valuable tended to 
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vary according to the role or stakeholder position of the interviewee. More specifically, most 
researchers tended to perceive the social value of research in provincial health facilities as residing 
in its contribution to knowledge, and in its value to future beneficiaries through its effect on policies, 
guidelines and clinical protocols, as exemplified in the following quotes: 
I mean, we’re in the business of providing evidence that will inform policies and decisions so 
it’s critical. (Interview 3; Researcher)  
 
So there’s multiple studies we’ve had … that have made not only local changes … but also 
changes to international guidelines. (Interview 5; Researcher)  
 
Ok we have had a number of standout things happen with research here. … We’ve have been 
involved in multi-national observational work … which basically has resulted in a new clinical 
entity being described … in periop[erative] medicine. (Interview 2; Physician researcher)  
 
Oh certainly it’s very important. … and for many reasons … our province is … I think has one 
of the highest threats or prevalences of infection … So I think the population in this province 
need to improve on health aspects and this can only be achieved if we do research. 
(Interview 4; Physician researcher) 
 
And the only reason you can make decisions like that is by having your decisions being 
evidence based, not impartial [sic], totally above reproach - you can only do that when you 
have a good summary of evidence … to say well this is not my emotion, you know my whim, 
but this is best for the people. (Interview 15; Researcher) 
 
Some health managers also tended to value the contribution of research to improvement of clinical 
protocols and guidelines, but rooted this value in the beneficial impact on KZN specifically. They 
valued the contribution of research to their health systems issues, in helping the Department 
develop practical interventions for problems, and as the third quote in this paragraph shows, tended 
to emphasise this over the contribution of research to new knowledge.  
Overall we need it and that is how we can go on as a health system… trying new things and 





Our service will get more quality so we need to know the gap because wherever we are we 
have a gap, we have a weakness. So we need to find our gap, our weakness so that, that is 
by the analyses of ... Doing more research so that we can get more implementation of 
research projects that is my belief. (Interview 8; Health manager) 
 
… research should be used for action - some sort of action so I answer that with some 
reservation in the sense that if there is research being done there must be something that 
comes out of it apart from simply understanding something better … there must be a short 
term or long term impact for the Department of Health in general. (Interview 7; Health 
manager)  
 
Some health managers perceived the value of research in provincial health facilities as located in the 
potential benefits to the healthcare system, i.e. they tended to value research that would lead to 
improved operations, improved functioning of the health care system or improved patient 
outcomes: 
The positive one is where operational research is conducted, where it will make us re-think 
the way we do things (…) I love them because they are also simple and even simpler to 
implement the recommendations. (Interview 1; Health manager) 
 
Research and practice and clinical outcomes go hand in glove – if you leave out one and think 
you can survive without it we will have problems. (Interview 6; Health manager) 
 
For example, minimal invasive procedures which result in better management of patients 
and quicker responses to treatment, decreased average length of stay. (Interview 6; Health 
manager, page 1) 
 
… one of the studies is the … in terms of HR “what is the impact of EPMDS in the workplace” 
so we need to know why we implementing the employment management to improve then 
we can see whether the EPMDS project or programme has affected to or changed the people 
behavior and attitude and the work ethic … (Interview 8; Health manager) 
 
In valuing research conducted at public health facilities, health managers tended to assign weight to 
perceived ‘concrete’ benefits such as human resource development and capacity-building for health 
workers, as well as building infrastructure.  
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But for me it will even improve the health system more if the skills are also imparted on the 
people that do day to day work. (Interview 1; Health manager) 
 
We have researchers that are very sensitive of what is happening, of the shortages of staff 
and the resources constrains that are there (….) Some even put in IT equipment in facilities, 
some assist with … with technical assistance, some clinical assistance, but others just come to 
gather information that you have, and take it and go and analyse … (Interview 18; Health 
manager, page 4) 
 
Health managers perceived research as less valuable when it appeared to detract from the 
healthcare system by using resources meant for non-research patients. Whereas researchers seldom 
raised issues of concern about the conduct or effects of research in health facilities, health managers 
did so frequently and at length. One of their major concerns was the burden that research placed on 
health facilities and on the Department of Health, primarily in terms of the use of Departmental 
resources in research projects.  
… they should not be using hospital resources for doing their study and that’s where they 
assume that once the research is approved they can use resources of the hospital for the 
research. (Interview 7; Health manager)  
 
 … there are “whistle blowers”- people who complain that people are doing research and we 
are used in the process. So they complain that we do see things happening but we realize 
that this is not part of our work. It’s part of someone’s study. (Interview 10; Health manager) 
 
The types of resources managers were particularly concerned about were hospital beds, diagnostic 
tests, and researchers’ use of Departmental staff for data collection:  
… we always have a problem with beds for patients but then I discovered there are a number 
of beds that are reserved for just clinical trials and I don’t think that’s fair. (Interview 1; 
Health manager) 
 
I think the biggest problem …. [is] where they assume that once the research is approved 
they can use resources of the hospital for the research and the sponsorship doesn’t get used 




 ….Sometimes the staff has to collect the data (like give out file(s)). (Interview 8; Health 
manager) 
 
Some of the researchers recognised concerns about resource-use and the importance of investing in 
health infrastructure and support for patients (such as computers for hospital wards, blankets for 
patients).  
If we are running a research project in the facility we provide our own staff, we provide our 
own resources, and in fact almost on a compassionate basis - we provide additional 
resources to the facilities. (Interview 3; Researcher)  
 
It’s like my mantra for the past ten years you know we will not give you more work - we will 
take away you know work from you but sometimes inevitably .. it’s like impossible not to …. 
(Interview 9; Researcher) 
 
However, some researchers questioned the degree to which expectations of material investment 
were appropriate and questioned the limits of such investments:  
I’m not a bank and I am unable to utilise the sponsor as a bank …. I completely understand 
that somebody is coming with fancy whatever it is - nice computers and we [the researchers] 
have an office and their [government] staff is crowded and so I do know that it’s a fine 
balance to work. (Interview 10; Researcher) 
 
In addition, one hospital manager appeared to question the value of too much research being 
conducted in one site. She perceived that certain hospitals were more utilised for research than 
others, for example, hospitals which cared for patients with conditions of interest to researchers. 
Her hospital was one such institution, and she said that at times as a manager she did feel 
‘overwhelmed’ by the number of research proposals they received, asking ‘Are we the only 
preferable site for research?’ (Interview 6; Health manager).  
 
Almost half of the researchers perceived that some gatekeepers to health facilities did not value 
research in the same way, or according to the same criteria that they did (i.e., they did not attach as 
much importance to the knowledge-generation component). This in turn may have impacted on 
their perceived quality of relationships (discussed further under Theme 2). Researchers said:  
Last thing that I find extremely frustrating is there’s not a … a sense of importance associated 




One of the studies it was bought up you know what is my …. my responsibility as a 
Department of Health employee, … getting involved in research? ….. And … and I mean at 
that level for someone to ask you know why are you as a Department of Health employee 
getting involved in research … you know implies that that individual doesn’t understand the 
importance of research … (Interview 5; Physician researcher) 
 
Well I don’t think the Department realises how important the evidence base is for what they 
do. I think that there is a responsibility for the Department to really look at their data and use 
it for their planning and their programmes. I don’t think they do that. So if you don’t do that 
then obviously research and evidence and data is not related to you, you’re just going to 
continue doing whatever it is that you do. (Interview 16; Researcher) 
 
…people are busy and they’re being dragged in ten different directions; and they maybe 
don’t have the time for research… (Interview 15; Researcher) 
 
The different value assigned to research by some health managers was attributed to inadequate 
understanding of the research’s scientific merits and purpose, as reported by one health manager 
and echoed by two researchers. This inadequate understanding reportedly impacted on health 
managers’ ability to engage with researchers and to impact on the health research agenda, as shown 
in the quotes below:  
…because for me it’s one of those things where I’m like “why are we even doing this” but 
then again [it’s] just me - as a programme person I have not much research experience. 
(Interview 1; Health manager) 
 
They [health workers and managers]…they don’t understand that [the study results] so we 
need to, as researchers, to come up with a better way of explaining things and I’m not sure if 
that’s necessarily possible. (Interview 3; Researcher) 
 
I think the main constraint is that people [DoH staff] don’t see themselves as researchers and 
they don’t think they can do that and therefore they don’t want to get involved with research 




In summary, the findings reported under Theme 1 indicate that, whilst most interviewees valued 
research in public health facilities, they differed on the aspects of research that made it valuable. 
Whilst researchers tended to value the contribution of research to knowledge and future 
hypothetical beneficiaries, and its future impacts on health and health care, health managers tended 
to value its benefits to the current health care system. Also, they perceived research as less valuable 
when it used system resources, and detracted from service delivery. Both groups reported some 
sense that the other group valued research differently.  
 
4.3 THEME 2: STRAINED RELATIONS  
 
This theme sets out the views of interviewees on the relationships between researchers and health 
managers in the KZN Department of Health, and their viewpoints on what factors impacted on these 
relationships. These perceptions are set out in the paragraphs below, categorised according to the 
‘chronology’ or sequence of the research process where they emerge, namely conceptualisation, 
review, conduct and results dissemination. The perceived primary concern (such as communication, 
trust, respect, transparency, and accountability) at each stage is also set out.  
 
Most interviewees perceived the relationship between researchers and provincial Department of 
Health staff as strained. Strained relationships were reported in all stages of the research process, 
from the first stage, that is, the conceptualisation of the research question, to the final stage, that is, 
the dissemination and utilisation of research results.  
 
A few interviewees reported that relationships were generally poor. This is exemplified in the 
following quotes: 
I think, my impression is that research in services there’s not a lot of collaboration. Not 
everywhere but in general I don’t think that there is marriage in the same way that I don’t 
think that the Department works very well with the staff that are working in academic 
institutions. (Interview 16; Researcher) 
 
… you know I think it started with [names former SA Minister of Health] and it’s a sort of 
antagonism towards researchers … and to some extent it’s being carried on even by the 
present Minister … just a slight antagonism to the researchers instead of embracing them 




However, it is worth noting that a minority of researchers and health managers characterised their 
relationships as generally positive, as these quotations show. 
… it’s quite simple. I engage well with them; I get the responses that I need; we work very 
well together. I’m quite happy with the researchers … (Interview 7; Health manager) 
 
… and at their sites [provincial health facilities] there was always a sort of good relationship 
which was … which was key. (Interview 15; Researcher)  
 
4.3.1 CONCEPTUALISATION  
A few researchers reported the view that it was important to engage Department of Health staff at 
the first stage of research, that is, the conceptualisation of the research question.  
I think that [involving DoH at development of research question] is very important for various 
reasons. It improves the research and it also improves relations. Think about it - a person 
working in the job probably knows more about it than anyone else … so you really want to 
engage on the topic you’re researching earlier on so that you can formulate research 
questions. (Interview 16; Researcher) 
 
However, this was experienced as challenging - as set out by these quotes:  
… for research the first thing I think is identifying the problem… I think the difficulty is often 
what you see as a problem may not be seen as a general … so I think the one issue is … is 
determining the priorities of research … everyone has their own opinion you know of what’s 
… what’s important. (Interview 5; Physician researcher) 
 
What we found difficult was at that stage [conceptualisation of research question] was that 
we couldn’t just easily communicate with the appropriate programme manager or general 
manager at province … To get a flat out opinion on what their feeling was. Um … We would 
pop in … or directly email proposals to the appropriate person … But even being able to set 
up a meeting at that point was … was often challenging. (Interview 15; Researcher) 
 
Three health managers expressed their views that the researcher-health manager relationship at this 
stage was characterised by inadequate engagement, ascribed to a lack of respect for managers as 
suggested by the third respondent, or a lack of communication, as suggested by the second and 
third respondents.  
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… in general I haven’t come across anyone that approaches me for the conceptualisation of 
the question or anything like that… (Interview 1; Health manager) 
 
No, no … they only start involving the Department when they are seeking for approvals … 
and that’s already at a stage where they already have funding for that research so they are 
bound to continue with that research … (Interview 17; Health manager) 
 
First you don’t want to be funny but I like to be respected not as a person, I mean as an 
institution - and then it’s really difficult when someone is pushing you to [sign support for 
research project] … first is there a need at [names provincial hospital] for this research, or is it 
your need because you need to have that research to graduate, but is it really interesting? 
(Interview 13; Health manager) 
 
A fourth manager complained that the hospital received “ready-made research proposals” and that 
inadequate consultation with facility managers early on in the development of a research project 
had an adverse impact on planning for the hospital (Interview 6, health manager).  
 
Finally, some perceived that health managers were inadequately involved in this stage because 
health managers themselves were under-resourced (had inadequate time or training or knowledge) 
to engage:  
I would love to be involved in the conceptualisation of research and planning and so on but it 
needs a little bit of resources in terms of getting a dedicated staff member even if it’s not 
someone in research but someone to help with the paper work and that sort of thing as well 
… (Interview 7; Health manager) 
 
… but we look at research as something so specialised that it’s something that you cannot 
do… (Interview 1; Health manager) 
 
At this early stage of the research process, representatives from both stakeholder groups reported 
that engagement was important, yet both groups reported frustrating experiences in the researcher-
DoH relationship at this stage. Certain health managers reported experiencing inadequate 
communication about the research concept (late or not at all), while some questioned their own 
capacity to be meaningfully involved at this stage. Certain researchers experienced frustration with 
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managers’ unavailability for early consultation meetings; and also perceived that health managers 
had different priorities to their own. 
 
4.3.2 RESEARCH APPLICATION PROCESS 
As outlined in the literature review, the research application process to conduct research in public 
health facilities in KZN involves obtaining a letter of support for the research from the facility or 
programme manager concerned, then submitting this together with the protocol and a letter of 
provisional ethics approval to the KZN PHREC for final permission. Researchers often did not 
distinguish between these two components, and at times conflated the application process of other 
regulatory bodies (such as the Medicines Control Council and RECs) with that of the Department of 
Health. However, only their perceptions related to the Department are reported here. 
 
Researchers expressed frustration at the long duration of the application process, and described 
experiencing inefficiencies, inadequate accountability of staff engaged in the process, and a lack of 
transparent communication around the process of review 
 
The second thing for also time constraints is the time it takes to get approval from all 
authorities - from ethics to Department of Health to even the site permission - it takes time … 
(Interview 4; Physician researcher) 
 
I think we should say … in so many weeks it will be reviewed and you will have your decision 
in so many weeks … It’s unacceptable that you just have to wait and wait … (Interview 2; 
Physician researcher)  
 
One researcher perceived that the long period of review was due to inadequate capacity within the 
Department to comprehend, and make decisions about, research proposals. 
... there needed to be some sort of capacity development there to … to enable them to at 
least read an abstract and understand what the major implications of the study are … 
because when they didn’t they would sometimes sit on it for three months and only escalate 
to district after three months with back and back discussions … but you would never get to 




Related to this was the perception reported by one researcher that Departmental managers, who 
were supposed to give letters of support, were unwilling to take decisions around research projects 
related to lines of accountability. 
… people don’t dare to take ownership or take responsibility to make decisions … Right? So 
there is always a “yeah this is really interesting but you know it is not me, it is like the head of 
so and so …” and then the … the responsibility is deferred … (Interview 10; Researcher) 
 
One researcher questioned the added value of review by the Department of Health in addition to a 
number of regulatory and review bodies, and expressed frustration at the protracted period of 
review:  
… so it’s protocols that have gone through FDA etc. etc. … lots of other countries, then we go 
through our own ethics, then we go through the MCC, and then we go through the 
Department of Health, and I … I find it really frustrating to still have queries about the 
protocol when it’s a protocol that has been seen literally hundreds of times around the world 
… and been approved. (Interview 2; Physician researcher)  
 
Several researchers perceived the provincial Department of Health as inefficient and unaccountable 
during the review process, which was an important cause of concern:  
… [the review took] five or six months and I could not um understand the reason because 
they asked for re-submission of the same documents that were submitted at the beginning … 
(Interview 4; Physician researcher)  
 
… well we did an application, and then it was … a few months and then they came back to 
me saying I must redo the application because now there’s a new form… (Interview 2; 
Physician researcher) 
 
Furthermore, the following researcher was of the view that adequate and efficient review depended 
on a personal relationship between the researcher and the gate-keeper involved in the review. 
What makes a huge difference is um is knowing somebody. ….. Not just with research but 
especially with research… it makes a huge difference in terms of ah … if you know who you 





Another researcher bemoaned the lack of clarity in criteria for obtaining permission from various 
levels of the health service; where one facility or manager may provide the letter of support to 
conduct research, another may not, without communicating an adequate reason for the refusal. 
…that you know you go through like a year of approval processes and you talk to I don’t 
know how many people, you know – Department of Health ethics, MCC you know whatever 
and municipalities and the clinic and hospitals and things - and then you finally start 
recruiting – you will always, always, always, always will there be a person who will say “I 
have never heard about this!” you know, and that has the potential of like really rocking the 
boat - “I’m gonna stop recruitment at this clinic, at this trial and this clinic! I have never 
heard about this!” (Interview 10; Researcher) 
 
A researcher described experiencing Department of Health staff as frequently changing, and where 
new staff might understand or interpret guidelines for supporting research differently from their 
predecessors. 
…. because there were interim CEO’s and interim you know medical managers you know and 
that was changing every six months. So whenever the previous one would put something in 
place the next one would change. And we’d need to re-engage… (Interview 15; Researcher)  
 
In the view of two researchers, the effect of the prolonged and challenging review process, which 
included the Department of Health process, was that they had lost or would lose funding and 
research opportunities. 
We’ve lost … we and other research organisations have lost a lot of funding …. in big grants 
because of um delays in regulatory approvals. …….and there’s actually there’s been some 
networks that we’ve ah been excluded from and reason cited was delays in regulatory 
approval… (Interview 3; Researcher) 
 
…. we have to compete … for grants on a global scale, so if you have a study that’s being sent 
out to multiple sites and they’ve … you know we take a year to get approval …. you’re never 
going to be awarded those … those grants to run those … studies. (Interview 5; Physician 
researcher) 
 
Health managers on the other hand, perceived researchers as unrealistic in their demands for 
speedy response times, with one manager citing the necessity of consulting with the relevant clinical 
departments in the hospital, as well as managers for parking areas and security, before providing the 
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letter of support for the research (Interview 6; Health manager). Another facility manager perceived 
researchers to be unwilling to consider their points of view, even when it came to legal issues 
affecting the conduct of research.  
So they would take tissue from that, so for them it is something that is discarded but they 
don’t take into consideration the fact … of that guide on the use of human tissue; so then 
even the doctor(s) themselves just wrote we need this thing finalised quickly and 
unfortunately the provisional ethical approval did not even look into that. They needed to get 
approval from the institution so I had to indicate that please just look at the Tissue Act and 
understand how to take care of human tissue. You don’t just take a piece and nobody knows 
what you are going to do with it. …. one had to make them aware of some of the processes 
that are in place but in most instances they just want to do research and they don’t want to 
hear about other things. (Interview 11; Health manager)  
 
At this stage of the research process therefore, researchers perceived health managers involved in 
the review process to be inefficient, unaccountable and under-capacitated. They expressed concerns 
around the prolonged review process, which was difficult to understand and characterised by a lack 
of responsiveness and a lack of transparency on the part of the Department of Health. Health 
managers on the other hand experienced researchers as overly demanding, and unrealistic in their 
expectations regarding a speedy review process.  
 
4.3.3 CONDUCT OF RESEARCH  
At the third stage of research, that is the conduct of the study, tensions in the relationship were 
expressed primarily by health managers, who were reportedly mistrustful of researchers’ actual 
adherence to their written research protocols and to sound ethical practices such as in securing 
informed consent and safeguarding data.  
I always wonder what if [it] doesn’t go as planned, are they promptly coming back to us to 
say “guys this is the problem”, or do they try other things and then it becomes worse because 
we’re also not there to actually follow up what they are doing …. I think my other concern is 
about getting an informed consent from patients. I feel as a Department once we see in their 
paperwork in their protocol what they would do but we don’t know if they physically do 




…. that is something that I also have a concern about in terms of what they say and how they 
go about collecting the data and safeguarding the data and maintaining the security and so 
on we can only go by what they put on paper for us… (Interview 7; Health manager). 
 
One manager was suspicious that researchers added research questions as the research proceeded, 
beyond those originally specified in the protocol  
they start off researching on measles and then add sub-titles of addressing something else. 
(Interview 6; Health manager) 
 
Furthermore, some health managers were mistrustful of researchers’ motivations behind the 
conduct of research in public health facilities.  
I think from all research that are coming probably about 25-30% truly have an intent of 
improving services or having some sort of benefit for the Department, whereas that 
remaining 75% or so is mainly to get the MMed or that primary degree … (Interview 7; 
Health manager)  
 
Health managers questioned whether the conduct of the research might undermine or compete 
with service delivery in their facilities (as set out in Theme 1). 
I’m not sure what is the problem for our institution whether it’s big or not I don’t know. But 
all the time our institution is a pilot for the pregnancy study, for the PMTCT and now I think 
it’s the NHLS doing they project here - we are involved a lot. But usually there is no problem. 
The research has no problem; the problem is the participant and the staff. Sometimes the 
staff has to collect the data [like give out files]…. (Interview 8; Health manager)  
 
… there’s also a lot of tension between facilities in terms of service delivery …. and research 
staff. Um … there’s often conflict between research staff and facility staff because it’s seen as 
a … as an extraneous …. activity. (Interview 5; Physician researcher) 
 
At this stage of the research process, relationships were characterised as strained largely due to 
health managers’ mistrust of whether researchers would adhere to protocols, and to described 
procedures for securing consent, as well as honestly report problems arising during the conduct of 
the research. They did not always trust that the research would not undermine service delivery, 




4.3.4 DISSEMINATION AND UTILISATION OF RESULTS 
At the final stage of research, the strained relations were generally attributable to lack of 
commitment to the dissemination and utilisation of research results, by both sets of participants; 
health managers claimed that they seldom received any feedback on completed research, and 
researchers reported that there was no interest in research results when they did try to report them.  
 
The following quotes from health managers illustrate their perspectives:  
…. there is no feedback as it is supposed to be in the protocol. There is no feedback to us as to 
where we are. Not … [even] just to mention that the research is finished. (Interview 13; 
Health manager) 
 
Since I started [two years prior to this study] to collect the research proposals, not a single 
one of them has actually came back to us and said that this is what we have discovered and 
this is how it can benefit your hospital. ….. so I tend to doubt if people truly mean what they 
say in their protocols. (Interview 7; Health manager) 
 
The studies are done, people are presenting at international conferences and whatever the 
findings are we don’t know how they can help the Department … (Interview 11; Health 
manager) 
 
One health manager said that her hospital had only received formal feedback on research once in 
the previous six years, and argued that researchers respected neither the terms of reference of their 
research permission, nor the right of the Department to get feedback (Interview 6, health manager).  
 
One manager reported inadequate participation by researchers in a formal feedback session for all 
research conducted in the hospital: 
We….we were thinking that you’ll get people responding and we’ll have to you know to … to 
… assess who can present, who can’t present …. but we got so few responses that everybody 
who submitted will present anyway. (Interview 11; Health manager) 
 
However, certain researchers reported that research results were inadequately considered by 
Departmental staff even when these were communicated:  
…. [names hospital] requires me to [send] my yearly progress report … but I’ve never received 
a query on that progress report … so you know no one’s really interacting with that report … 
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you know when [the research] gets published we send ah the publication to the facility but 
no one actually reads that …. (Interview 5; Physician researcher) 
 
So I have said “Please, I want to come and talk and give this talk and I want to disseminate 
the information and I want to, want to, want to, want to …” … “Yes, we’re going to invite 
you” …. Never happens! I have said this so many times and it just never happens. People are I 
don’t know too busy, or too whatever … (Interview 10; Researcher) 
 
I find that (laughs) in theory everybody’s interested but … being in the health service, the day 
that you schedule to go and tell them about the research - you know something’s happened 
…. and their minds are completely somewhere else …. (Interview 12; Researcher) 
 
One health manager agreed that the Department did not engage sufficiently with research results 
when these were communicated and attributed this to inadequate ownership from the Department:  
…. it’s also very tiresome on their [researchers’] part to be able to get us as well to sit down 
and listen to their results [laughs] because mostly you find that it would take about three 
months for a partner to secure an appointment … with provincial staff ….to be able to give 
feedback. ….. So there is a lot of work that is going on but unfortunately even the results, 
some the Department would take and some the Department would not take because they 
are not fully involving internal people in that research …. there is no Departmental ownership 
(….) of those research studies because it is not conducted by the Department. (Interview 17; 
Health manager) 
 
One researcher expressed mistrust that the Department of Health would implement research results 
timeously. 
…the prevention of mother to child transmission …. I mean it took twelve years for that 
finding to be implemented - why? (Interview 3; Researcher) 
 
However, another researcher applauded the rapid implementation of communicated research 
results in certain situations in South Africa. 
… somebody in the Department of Health you know, National level, reads a … a research 
paper – “this is the new way, this is what we have to do, ooh ooh ooh [claps hands]! Change 
tomorrow!” It’s fixed. Whereas you know anywhere else, well you know where we have to go 
through the WHO, and the USAID and all these things ….. So there are certain things that 
43 
 
happen immediately that I think are a huge advantage for this setting to be able to do that…. 
(Interview 10; Researcher) 
 
One health manager felt that once communicated research results had been implemented, the 
evaluation of interventions was poor: 
With other research we don’t know what is going on - even we did a summary, we made a 
follow [sic] to see whether the implemented project is effective or not; for example now we 
are doing the MMC [male medical circumcision] because of the 60% of HIV prevention it 
could give, but we don’t know after 10 years what it will be… (Interview 8; Health manager) 
 
At this stage of the research process, the relationships seemed to be characterised by mutual 
blaming. Health managers reported that researchers did not make the effort to give them feedback 
on research results, and researchers claimed that health managers did not make the effort to engage 
with them on research results. On both sides, a lack of accountability on the part of the other side 
seemed to be implied. Whilst managers claimed that they seldom, if ever, received feedback from 
researchers on completed studies, researchers were of the view that managers did not avail 
themselves for feedback meetings, nor did they engage with research results when researchers 
communicated them. Finally, even when research results were disseminated and implemented as 
policy, the evaluation of these interventions reportedly failed to happen.  
 
In summary, the findings reported under Theme 2 indicate that both researchers and managers 
perceived that the relationships between them were strained, and such strains are evident over all 
stages of the research process. Strained relations appear underpinned by distinct concerns at 
different phases. Major concerns include trust, accountability, and transparency. Relationships were 
characterised by mistrust (for example, mistrust by managers that researchers would adhere to their 
protocols), perceived lack of accountability (for example, researchers’ sense that managers did not 
respond to efforts to communicate results), perceived lack of transparency (for example, 
researchers’ sense that the review process was arbitrary and its criteria obscure), and perceived lack 
of capacity (from both researchers and managers) on the part of Departmental managers to engage 




4.4 THEME 3: STRENGTHENING PARTNERSHIPS  
 
This theme reports on how interviewees could envisage stronger research and more robust 
stakeholder relations. Many ideas were shared across both managers and researchers, with many 
overlapping ideas from each group, and little direct conflict between these ideas. Respondents 
discussed ways to improve the process of conducting research in KZN provincial health facilities, 
which would in turn improve inter-stakeholder relations in the province, and indirectly, further the 
realisation of the social value of health research in KZN. These are outlined below in terms of the 
‘chronology’ of the research process. 
 
4.4.1 CONCEPTUALISATION  
At the stage of setting the research agenda and conceptualising research questions, the importance 
of more discussion, in a formal regularly-scheduled forum, was underscored by both health 
managers and researchers.  
We have … a technical advisory committee that sits on quarterly basis and we have the 
research that supports TB involved there. So one of the things that we do in that committee 
is to kind of guide the research agenda for the programme which really helps us …. 
(Interview 1; Health manager) 
 
…. to start with this like you know forums to bring people together ….. you know that would 
be …. I would love it if we could do that …. That doesn’t come just from me it comes from 
other researchers as well and other clinical … staff … (Interview 10; Researcher) 
 
The following researcher felt that it was crucial to discuss the proposed research extensively with 
the Department prior to conducting the research, in order to gain support from the Department for 
the research, and in so doing, to pre-empt difficulties with the conduct of the research and to 
enhance the probability that the research results would be used.   
I think … a lot of it is required as … before the study happens, you have to (…) ensure that you 
inform everyone what’s happening …. and where where the study is placed, what the study 
can add to the system …. and also what the ultimate goal of the study is….. So sometimes the 
the study may not be adding to the service delivery of the site …. but making people 
understand that there’s a … there is a bigger goal to the research …. so eventually people 




4.4.2 RESEARCH APPLICATION PROCESS 
At the second stage of the research process, that is the application for permission to conduct 
research, researchers made recommendations for the Department of Health process (issuing of 
facility or programmatic letters of support followed by final approval by PHREC), as well as for other 
regulatory bodies. The latter are only included here when they relate to Departmental processes. 
 
One researcher suggested that the different review bodies involved in the application process should 
work together so that reviews take place concurrently, thus reducing the period of review. 
I still believe that the way we need to go is try and ensure that these processes run 
concurrently. …. I think um …it would really be good if the ethics committee and the 
provincial Department of Health …. sat on review boards together. So if a clinical trial goes to 
an ethics committee there should be a member of the Department of Health there ….so they 
can see the trial at that point …. not sequentially, not afterwards. (Interview 2; Physician 
researcher)  
 
Regarding granting support for researchers to enter the facility to collect data, one researcher said 
that managers at all levels of the health system needed to be better informed about Departmental 
processes and capacitated to take decisions, so that criteria for approval would be uniform across all 
levels of the health service, and decisions to support a study could be taken at the appropriate level. 
[Departmental policy on research] has to be disseminated down. You know like …. people 
don’t really understand what the systems are and they are afraid to take decisions and you 
know give approvals and things like that because they don’t know what the systems are … 
(Interview 10; Researcher)  
 
One health manager suggested that each health facility should have a research committee to review 
and give support for research projects. Although in practice, such committees might slow down the 
review process, it is possible that increasing the capacity of a committee (as opposed to a single 
manager) would result in faster decision making.  
I think there used to be research and ethics committees in the facilities - maybe if those can 
be revived. Make sure that each and every facility has those people, maybe get them trained 






4.4.3 STUDY CONDUCT  
In order to ensure adherence to research protocols, and to ensure patient safety, a few health 
managers suggested enhanced monitoring mechanisms for research conducted in public health 
facilities. 
If somebody was looking at it from time to time reviewing, especially where we know that 
this is a bit dangerous and this is a bit gambling, so maybe those are the studies that we can 
monitor, organise clinicians within the Department that would spot check whether [things] 
are going as [they’re] supposed to, are the patients not being compromised and what is 
happening with those patients …. (Interview 1; Health manager)  
 
I think the key (…) that is monitoring what goes on with the study; it could be a very difficult 
thing but if there could be some monitoring mechanisms especially with the prospective 
studies you know where people can monitor from time to time what is actually going on … 
(Interview 7; Health manager) 
 
Such monitoring should include ensuring informed consents are taken correctly from patients.  
I feel we should as a Department maybe at a facility level where the study is conducted 
maybe just sit in when they’re obtaining a consent from a patient so that we can really be 
sure that the right processes are being done there. (Interview 1; Health manager) 
 
During the conduct of the research, one researcher suggested that Department of Health staff 
collaborate as research partners, and this view was echoed by a health manager. 
… I think it’s really important that you even get a research collaborator from the province 
guiding and ensuring that that project is helping directly address the concerns or questions … 
they have …. (Interview 15; Researcher) 
 
… the research itself can be improved by … like I said earlier on, involving the Department 
employees as well in in the research …. so that at least in each research that any partner is 
conducting, there is somebody from the Department who is also an investigator in that 
research project… (Interview 17; Health manager)  
 
Another health manager emphasised the importance of transferring research skills to Departmental 
staff during the conduct of the research project. 
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So I think it can be made better, it’s strengthening the health system in a way but if the 
people on the ground who are doing day to day service delivery can be empowered to look at 
things differently. Even with the routine information that they collect, just the analyses of 
that information doesn’t happen and it’s a big miss that could help the health system…. 
(Interview 1; Health manager)  
 
The need to inculcate a culture of research within the Department of Health, and for research to be 
conducted routinely by Department of Health staff, was expressed by this researcher and these 
health managers. 
I’m not going to be very pedantic about it … I think the Department has an obligation to do 
research, period. …. Everybody should be encouraged to do research all the time and I do 
think that routine collection of data and evidence by clinicians and other research people - 
that constitutes research - so it’s a matter of encouraging people to look at their data, 
interpret and change …  (Interview 16; Researcher)  
 
… I feel that we … we do not stop to document what we do as a Department …. and that is 
very important and then we find people who are telling our story outside … without us 
(Interview 17; Health manager)  
 
If there was a way of having workshops….. to make people aware that there is so much that 
can assist our output and our functioning if we were to do research not necessary aligned to 
a qualification but about what we do in our everyday work…. (Interview 11; Health manager) 
 
We have I must say lot of research done here by people, some are being published but I think 
it’s still minimum compared to the number of professions that we have … there is so much 
potential. (Interview 13; Health manager)  
 
An important way to capacitate Departmental staff to conduct their own research was through 
mentorship, as this health manager described: 
Mentorship can bring people closer together. (….) So if (…) the current researchers can 
provide mentorship to Departmental staff as well, it will help the Departmental staff as well 
and improve the relationships between the researcher and the Departmental staff as well. 




One physician researcher said that the Department should make it easier for external organisations 
to support research within the Department. 
…. also when it comes to external stakeholders …that they would like to donate and support 
…. We find very difficult um… that the ah Department of Health um will allow this donation 
before a very very long procedure to um follow regarding um well the clearing and the 
accepting these um items…. (Interview 4; Physician researcher) 
 
Once the research project was completed, and as a way of minimising the perception that 
researchers “dump” patients back into public health facilities once the research is over, one 
researcher recommended: 
What we do is we’ll routinely get [patients] assessed via the Department of Health clinics so 
that they have a file, ah they have you know all the necessary documentation …. in the clinic 
already …. …. and then we take them into a research facility … so that when they need to go 
back … everything is done already … and it’s not that they’re starting all over again ….. what 
we have learnt was when you start referring them back and there’s no cards, there’s no files 
there, people say … feel that you’re dumping the patient on them … so if there’s a card and 
there’s a file there … you know …. the perception is that these patients are already part of 
the system. (Interview 5; Physician researcher)  
 
A health manager further suggested that patients who are also research participants should be 
followed up for a longer duration, and that sufficient information on these patients should be given 
to the Department on completion of the research, in order to avoid such patients placing a burden 
on the Department after the research. 
Maybe we need to make sure that somehow with clinical trials conducted maybe patients 
that have been exposed are followed for a longer period so that the unintended effects can 
be picked up a bit earlier and make sure that we have the patient within the finding of the 
study because then it becomes the DoH burden, because the patients are sick and sometimes 
it’s really difficult to treat these people because you cannot really link to whatever research is 
being done. (Interview 1; Health manager) 
 
4.4.4 DISSEMINATION AND UTILISATION OF RESULTS 
At the stage of feeding back research results, two health managers suggested that there should be 




…. there is no negative consequences for not doing so [feeding back] I guess. Whereas if 
there was some stage in the process that maybe when they want to publish or to sign off the 
dissertation or something like that, at that point confirmation should be made whether 
whatever was written in the permission letter was done with evidence, before the next step. 
(Interview 7; Health manager) 
 
A certain process must be there so that they need a letter before they graduate. Certain 
punishment, before they publish they need a letter from the institution where they conducted 
the research must give a proof letter that they receive the report no matter whether the 
institution use report or not… (Interview 8; Health manager) 
 
However, researchers felt that, rather than being coercive, the submission, receipt and utilisation of 
research results should be done willingly by all stakeholders; they felt that researchers and health 
managers should take pride in the research conducted in public health facilities, and should even 
take joint responsibility for wider dissemination of the results. 
I believe the Department of Health and the university are missing out here. They should be 
ensuring that these are um publicly reported. …. So I think there should be little snippets in 
newspapers …. about the research that has been conducted, ….what it means for people, so 
that the community start to understand the importance of the work and its implications. ….. 
We do important research …. we should be proud of it. People would engage more if they 
understood what we were trying to do. (Interview 2; Physician researcher)  
 
A representative from both stakeholder groups perceived that disseminating results would be 
facilitated by regular formal feedback sessions between researchers and the Department of Health, 
and this view was echoed by the researcher below. 
… if we can meet once or twice a year to get what has been done in that year…. (Interview 1; 
Health manager) 
 
You know when [names provincial DOH manager] was the [manager] we used to have once a 
year a provincial TB research day ….. and it was lovely! (Interview 12; Researcher) 
 
In summary, the findings reported under Theme 3 indicate that researchers and health managers 
shared several similar view-points regarding how to strengthen aspects of health research in 
provincial health facilities. However, the view of health managers that researchers who did not 
50 
 
submit feedback to managers should be penalised did not seem to be shared by researchers 
themselves. Interviewees made recommendations for each stage of the research process, and many 
of these related to more explicit and transparent communication, that is more regularly scheduled, 
and is more formalised. Others related to better monitoring of researchers, to assure Departmental 
managers of their adherence to their protocols, and the creation of a culture of research in the 
Department of Health, not least through capacitation and mentorship of Departmental staff by 





This chapter considers the most important themes arising from this study, and, in the light of 
relevant literature, how these can be related to the local and global context of health research and 
stakeholder engagement. The three themes, although distinct, are strongly related. For example, 
disagreement over the social value of research may inform strained relations between researchers 
and health managers, which may limit the extent to which research results are disseminated, valued 
and utilised. It is important that the inter-relatedness of issues raised in this study is recognised and 
that interventions are developed with this in mind.   
 
5.1 THEME 1: VARYING PERCEPTIONS OF SOCIAL VALUE  
 
All interviewees in this study perceived that health research was generally valuable; however, there 
were subtle but important differences between the way researchers ascribed value to health 
research, and the way that health managers did. Researchers tended to emphasise the inherent 
value of new knowledge generated by research, as well as the benefit of research to future 
generations as a result of this new knowledge. Health managers on the other hand tended to 
perceive the ‘incidental’ aspects of research as being very valuable, such as the development of 
Department of Health staff, infrastructure and health systems that might occur during the research 
process.  
 
This distinction reflects that drawn by King (2000), who differentiated between the benefits that 
accrue to future persons and society as a result of research (which she called ‘aspirational’ benefit) 
and the benefits that accrue to participants from the research (such as better clinical monitoring or 
more advanced diagnostic tests) (which she called ‘collateral’ benefits). King (2000) noted that 
participants’ motivations for enrolling in research may be rooted in the desire for ‘collateral benefits’ 
(Lutge et al., 2017). This study’s findings suggest that facility managers’ motivations for supporting 
research may also be somewhat rooted in the hope of collateral benefits, not so much for 
themselves but rather for the healthcare system in which they work (Lutge et al., 2017). At least 
some researchers in this province also considered the need to ensure such benefits for the health 




It is clear that so-called ‘collateral benefits’ may be highly valued by stakeholders of health research, 
especially those in low income countries (Kamuya et al., 2014; Lairumbi, Parker, Fitzpatrick, & 
English, 2012). In these settings, research may be seen as a tool for the improvement of health 
services, and as such, a means of promoting social justice (Lairumbi et al., 2012). In a country with 
profound inequities like South Africa (Leibbrandt et al., 2010), the role of research in offsetting 
health injustices has been supported (Benatar & Singer 2010).  
 
Also, leading ethics commentators (Emanuel et al., 2004; Emanuel, Wendler, & Grady, 2008) - in a 
popular framework for evaluating the ethics of health research - consider the benefits that research 
may confer to health systems to be an intrinsic part of its social value; and such benefits include 
capacity-building of staff and infrastructure-development. This stance, which is supported by some 
empirical studies (Kamuya et al., 2014; Lairumbi et al., 2012) confirms the idea that so-called 
‘collateral’ benefits should be considered as part of assessments of value during the negotiations 
around research projects. The capacity building of staff would have an additional benefit in that it 
would enable health managers to engage with researchers on a more equal basis, thus achieving a 
true collaborative partnership (Emanuel et al., 2004). The findings of this study suggest that research 
in public health facilities in KwaZulu-Natal should do the same, because key stakeholders in the form 
of gatekeepers value such benefits highly. 
 
This viewpoint is also consistent with the Fair Benefits approach (Participants 2004), which argues 
that stakeholders of research should negotiate the collateral benefits that will accrue as part of 
research, such as improved infrastructure and training of personnel. However, just as the Fair 
Benefits approach has excited some controversy (Lie, 2010; London & Zolman, 2010; Schϋklenk 
2010), so certain researchers in this study seemed to question to extent to which collateral benefits 
should be offered, perceiving the expectations of health managers as higher than they could 
reasonably meet. As seen in this study, health managers’ perceptions of the ample resources of 
researchers may fuel expectations of collateral benefits that researchers feel unable to provide. 
Because these collateral benefits were considered an inherent part of the social value of research by 
gate-keepers in this study, and because they were a potential source of conflict, it is crucial that 
researchers and health managers communicate more openly about expectations, and which of these 
can be reasonably fulfilled.  
 
Ensuring fair distribution of collateral benefits is important but conversely, it is also important that 
health managers do not feel that their institutions are being ‘over-researched’, as expressed by one 
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interviewee in this study. Although the term ‘over-researched’ is often undefined, with 
understanding of its meaning presumed rather than made explicit (Koen et al., 2017), the term is 
increasingly used in low and middle income countries (LMICs) (ibid). Importantly, for the concerns 
around strained relationships raised in this study, the term ‘over-researched’ seemed to be 
understood differently by researchers and research communities in a study which investigated 
stakeholders’ understanding thereof. Whilst research communities tended to spontaneously define 
it as exploitation, researchers were less explicit (Koen et al., 2017). It is crucial therefore for 
researchers and health managers to engage on this issue, come to a common understanding of what 
it means, and ensure that steps are taken to mitigate against this perception.  
 
This study found that researchers tended to value the knowledge-generation component of research 
highly. This perspective corresponds with the CIOMS Guidelines (CIOMS, 2016) which defines the 
social value of research primarily in terms of its scientific value. That is, ‘(s)ocial value refers to the 
importance of the information that a study is likely to produce’ (p. 1). This view also corresponds 
with the first iteration of Emanuel’s framework (Emanuel et al., 2004) where the social value of 
research was similarly defined as being the generation of ‘knowledge that can lead to improvements 
in health’ (p. 932). 
 
This study found that gatekeepers perceived research in public health facilities to be less valuable 
when it undermined existing services in the facilities in which it was conducted. This was an 
important concern of health managers, but was not spontaneously raised by researchers in this 
study. The potential detrimental impact of research on service-delivery in health institutions is 
addressed in Emanuel’s framework for ethical research (2004) where it is stated specifically that the 
socially valuable research should not detract from existing services and infrastructure (Lutge et al., 
2017) and “conduct of the research should not undermine the community’s existing health-care 
services” (Emanuel et al., 2004, p. 932). The use of Departmental resources for research without 
some appropriate compensatory benefit should no longer occur, and the provincial guidelines 
governing health research in the province have been amended to express this (KZN DoH, 2017).  
 
The social value of research has been recognised as an important part of what makes research 
ethical (CIOMS 2016; Emanuel et al., 2004; Emanuel et al., 2008; Emanuel, Wendler, & Grady,, 2000) 
and Emanuel et al. (2004; 2008) importantly recognised that the value in research may be defined 
differently by different stakeholders. This study supports this view, finding that different role players 
may value research differently. The finding that researchers’ and gatekeepers’ conceptions of 
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‘valuable’ research have subtle yet important differences means that it will be important for these 
parties to discuss and come to a shared conception of what makes research valuable, particularly in 
this setting (Lutge et al., 2017).  
 
Guidelines recommend that these differences should be approached with the relationship principles 
of respect and integrity (UNAIDS/AVAC, 2011). A clearer understanding of others’ perspectives on 
what constitutes valuable research may improve relationships between these stakeholders, and as a 
result may improve the conduct of research projects and the utilisation of research results (see 
Theme two below for further discussion on this). In addition, recognising that the ‘collateral’ benefits 
of research are considered by some stakeholders to contribute as much to the value of research as 
the ‘aspirational’ benefits may result in a shift in thinking about research, from a perception that the 
role of research is to improve health in the long term, to a perception that research should also have 
an immediate benefit in the settings where it is conducted.  
 
5.2 THEME 2: STRAINED RELATIONS  
 
The importance of strong and positive relationships between stakeholders in health research has 
been emphasised by a number of authors as key to achieving the goals of research projects 
(Emanuel et al., 2004; UNAIDS/AVAC, 2011). However, only a minority of respondents in this study 
characterized the relationships between researchers and health managers as positive, with most 
experiencing strained relationships at various stages of the research. This has important implications 
for the outcomes of research projects undertaken in public health facilities in KZN. The strain in this 
relationship could be likened to the friction generated by the movement of tectonic plates past each 
other; such friction can generate “major tidal waves or volcanic eruptions” which may be disastrous 
for the conduct and outcomes of research” (Martens & Roos, 2005, p. 73). Major relationship 
failures were illustrated by the failed HIV prevention trials undertaken in Cambodia and Cameroon a 
decade ago (Mills et al., 2005).  
 
In order to avoid such relationship breakdowns, it is important that stakeholders actively build 
positive relationships and maintain these over the duration of the research process. These 
relationships should not simply be based on contractual obligations, but should be personal 
(Martens & Roos, 2005) and reflect the following characteristics (UNAIDS/AVAC, 2011): respect; 
mutual understanding (which relies on socio-cultural and research competency); integrity (scientific 
and ethical); transparency (which is enabled by “open, honest, timely, and clear communication” - 
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UNAIDS/AVAC, 2011, p. 24); accountability; and respect for community stakeholder autonomy 
(which refers to the right of “community stakeholders … to support or refuse proposals to conduct 
research in a particular area” - UNAIDS/AVAC, 2011, p. 25).  
 
The above characteristics are not only held to be important in and of themselves, but are key to 
fostering trust between stakeholders which in turn is foundational to positive and collaborative 
partnerships in research (Emanuel et al., 2004; UNAIDS/AVAC, 2011). Relationship-building should 
span the entire research process, from conceptualisation of the research question to dissemination 
and utilisation of the research results (fhi360, 2012; UNAIDS/AVAC, 2011). This section discusses the 
relationship tensions raised at various stages. At each stage in the research process, the key 
relationship issues that emerged most strongly from the data are discussed.  
 
5.2.1 CONCEPTUALISATION  
The importance of engaging DOH stakeholders on the development of the research question was 
recognized by both groups of interviewees in this study; however, respondents perceived that such 
engagement seldom if ever happened, with DoH interviewees questioning the adequacy of 
communication at this stage. Some health managers expressed concerns that engagement at this 
stage was not respectful.  
 
It has been argued that the formation of collaborative partnerships in research requires 
commitment from all stakeholders (Emanuel et al., 2004); this commitment includes allocation of 
time for engagements over all stages of the research process, from all parties concerned, including 
managers in the Department of Health. This point notwithstanding, most ethical guidelines assign 
the core responsibility for engagement to researchers and sponsors (CIOMS, 2016; UNAIDS/AVAC, 
2011) suggesting that these parties that must assume the ‘lion’s share’ of responsibility for 
engagement practices at this stage. 
 
Representatives from both stakeholder groups viewed communication as problematic at this stage 
of the research. It has been argued that communication is not simply the transfer of information; it 
is rather the process through which stakeholders “build transparent, meaningful, collaborative, and 
mutually beneficial relationships” (UNAIDS/AVAC, 2011, p. 16). Effective communication enables an 




The cited experiences of some health managers that engagement practices at this stages smacked of 
disrespect underscores the importance of the Good Participatory Practice Guidelines which list 
respect as one of the fundamental characteristics of a mutually beneficial research relationship 
(UNAIDS/AVAC, 2011). In order to show mutual respect, research stakeholders must act in ways that 
“that value and honour each other’s perspectives and realities” (UNAIDS/AVAC, 2011, p. 22). 
 
Both groups of stakeholders reported some concern about whether health managers can contribute 
meaningfully to this stage of the research process, based on their capacity. Ethical guidelines 
acknowledge that there may be significant disparities in “scientific knowledge and technical skills” 
between researchers and key stakeholders such as health facility managers (HPTN, 2009, p. 17). 
Increasing research ‘literacy’ is recognised as a key goal of researchers’ stakeholder engagement, 
and arguably increases the likelihood of stakeholders making effective and informed contributions 
(UNAIDS/AVAC, 2011) and building research partnerships that are more equitable and therefore 
more truly collaborative (Emanuel et al., 2004).  
 
The perspectives that health managers may give on research questions are different from those of 
researchers and may enhance the relevance of the research question to the health services. It is 
crucial that these perspectives are elicited early on in the research process. As stated strongly and 
frequently in the Good Participatory Practice Guidelines (UNAIDS/AVAC, 2011), if key stakeholders 
are engaged early in the research process, they are likely to support the research more strongly and, 
once it is completed, they are more likely to incorporate research results into practice.  
 
5.2.2 RESEARCH APPLICATION PROCESS  
In this study, the major issues relating to the review process were raised by researchers, and related 
primarily to the time the process took (sometimes perceived to be due to duplication of review by 
different regulatory bodies) and the lack of transparency and accountability in the process.  
 
Researchers perceived that the review process took much too long, and that they were required to 
go through review processes with a number of different regulatory bodies which they felt duplicated 
reviews unnecessarily. These views resonate with views regarding the review process for TB vaccine 
trials in South Africa (Geldenhuys et al., 2012). Although review times for provincial health 
committees were not considered in this article, the median review time for the MCC was found to be 
122 days, and that for Research Ethics Committees was found to be 60 days (Geldenhuys et al., 
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2012). Review response times in Europe, the United Kingdom and the United States were noted to 
be much shorter than these.  
 
Like respondents in this study, the authors found the review process to be perceived as excessively 
long, which had implications for the administration and funding of the trials, as well as the perceived 
suitability of South Africa as a setting for such trials (Geldenhuys et al., 2012). The authors noted that 
there was high variability in review times for different protocols, and these times did not seem to be 
related to the complexity of the trials themselves. The authors found this lack of predictability to be 
frustrating, and ascribed it to a lack of capacity within the regulatory authority to review such trials 
(Geldenhuys et al., 2012). Indeed, in a review of clinical trials for neglected diseases taking place 
globally, the lack of regulatory capacity in many settings was found to be an important stumbling 
block for such trials (Bollyky, Cockburn, & Berndt, 2010). Given the importance of rapid review in 
determining a country’s competitiveness in clinical research (Lambers Heerspink, Dobre, Hillege, 
Grobbee, & de Zeeuw, 2008), the delays in review of research as reported by respondents in this 
study is a cause for concern.  
 
It was not only the length of the period of review that researchers found frustrating in this study, but 
also the necessity for applying to a number of different regulatory bodies (ethics committees, the 
MCC in the case of clinical trials, and the provincial Department of Health), and the perceived lack of 
value added by the Departmental review to the rigour of the research. Although little research has 
been conducted into researchers’ perspectives on the review process in South Africa, the frustration 
expressed by researchers in this study is echoed by that of researchers undergoing multi-centre 
ethics review in England, who faced challenges in terms of the high costs associated with applying to 
a number of different committees for the same application, and the lengthy review process which 
resulted in delaying the start of research projects (Tully, Ninis, Booy, & Viner, 2000). Similarly in 
Canada, different Research Ethics Committees have different applications forms and informed 
consent templates, which for researchers who are required to apply to a number of them, can be 
frustrating (Michael Smith Foundation for Health Research, 2007).  
 
From the description that follows, it is clear that there is duplication in the review of health research 
applications in KZN, as well as potential for confusion regarding the different actors and their roles in 
the process. The review of health research applications in South Africa is governed primarily by the 
National Health Act (no. 61 of 2003), and by the Ethics Guidelines of the National Department of 
Health (NDoH, 2015). These stipulate that all health research proposals must be reviewed by a local 
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(South African) REC accredited with the National Health Research Ethics Council (NHREC). Whilst the 
first RECs were only established in South Africa in 1977, it has been argued that the ethics review 
process in this country is rigorous and of a high standard (Cleaton-Jones & Wassenaar, 2010). In 
addition, all research conducted in public health facilities in KZN (or recruiting patients from these 
facilities) must be granted permission by the KZN PHREC (KZN DoH, 2017), and clinical trials must 
also be approved by the MCC. In most parts of South Africa, these application processes are 
sequential.  
 
In addition to the length of the application process, researchers in this study perceived there to be a 
lack of transparency about the status of their applications during the process of review. They 
perceived the criteria for Departmental approval of research to be opaque. Guidelines for 
Submitting Research Proposals to the KZN Department of Health are available on the Departmental 
website (KZN DoH, 2017) yet it is possible that as new managers enter their positions, they are not 
made aware of these. 
 
It is important to note that gatekeepers have significant influence over whether research (and what 
research) is conducted in the facilities which they manage. This influence may be exerted in different 
ways: by “limiting conditions of entry, by defining the problem area of study, by limiting access to 
data and respondents, by restricting the scope of analysis, and by retaining prerogatives with respect 
to publication” (Broadhead & Rist, 1976, p. 325). This influence may be exerted purposefully, or by 
default, if managers are tardy or negligent in providing letters of permission. Given their influence 
on the conduct of research, it is important that gatekeepers are made aware of their responsibility, 
and that the Department of Health ensures that gatekeepers exercise this responsibility uniformly 
and transparently.  
 
5.2.3 STUDY CONDUCT 
Relationships at this stage of research were strained largely because managers of health facilities 
and health programmes were mistrustful that researchers would do what they say they would do, as 
specified in their protocols. Trust has been argued to be an important component of collaborative 
partnerships as described by Emanuel et al. (2008). Without it, research relationships can neither be 
true partnerships nor can they be collaborative (Emanuel et al., 2008). However, trust is not 
established quickly, can be easily broken and research stakeholders need to take note of the time 
and effort required to build trust within their relationships (Martens & Roos, 2005). Bennett and 
Gadlin (2012) have identified three different types of trust, all of which are relevant to inter-
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stakeholder relationships in the conduct of health research. The first is identity-based trust, which is 
based on mutual understanding of each other’s “wants, desires and values” (Bennett & Gadlin, 2012, 
p. 5). The second is calculus-based trust, which is developed when people consistently keep their 
word, that is, do what they say they will do. The third is competence-based trust, which depends on 
faith in the skills of the person concerned. Gatekeepers in this study were particularly concerned 
that researchers would not adhere to their protocols for research; in other words, they expressed 
‘calculus-based’ mistrust in researchers. Specifically, they were concerned that researchers would 
not take proper informed consent from their study participants, and that they would not adequately 
safeguard the data they collected.  
 
A systematic review, covering the period 1966 to 2004, shows that the process of securing informed 
consent may be challenging and that research participants may not fully understand the research in 
which they are engaged (Flory & Emanuel, 2004). Furthermore, potential research participants in 
developing countries may understand proposed research less well than their counterparts in 
developed countries, after participation in an identical informed consent process (Diemert et al., 
2017). Ensuring participant understanding may require that the informed consent process continue 
over the duration of the research, in a way that responds dynamically to participant needs (Ssali, 
Poland, & Seeley, 2016). Although it is clear that some health researchers in KZN are aware of and 
try to overcome the challenges associated with the informed consent process (Lindegger & Richter, 
2000; Rautenbach, Lindegger, Slack, Wallace, & Newman, 2015), it appears that important 
stakeholders perceive that more efforts need to be made in this regard. These suggested efforts are 
discussed further under the third theme of this discussion.  
 
The protection of patient privacy and confidentiality is an ethical requirement of research (CIOMS 
2016; Declaration of Helsinki, 2013, article 24) and RECs which review research proposals are 
required to confirm that this is provided for in the protocol (WHO, 2011, p. 16). However, breaches 
of patient privacy and confidentiality in research do happen (Helgesson, 2015), and the collection 
and storage of research data using electronic methods has made the leakage of patient data on a 
large scale easier (Myers, Frieden, Bherwanin, & Henning, 2008). Indeed, thousands of breaches of 
patient data security occur every year in the United States (Taitsman, Grimm, & Agrawal, 2013). 
Although no major breaches of patient confidentiality in research have been reported in South Africa 
in recent years, and no actual breaches were reported by interviewees in this study, gatekeepers 
perceived that researchers may not be trusted to secure their data as stipulated in their protocols. 
This concern is one that should be addressed, and is further discussed under the third theme below.  
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Relationship strain at this stage of the research was characterised by gatekeeper mistrust of 
researchers’ motivations. There was concern that researchers are mainly conducting research to 
advance their own careers, and that their research, which may burden health facilities, does not 
benefit the facilities commensurately. Emanuel et al. (2004) stress the importance of sharing the 
fruits of collaborative research so that research is not perceived as exploitative and does not erode 
trust. Although there are examples of research projects not undermining, and indeed positively 
contributing towards, the health systems in which they are conducted (Angwenyi et al., 2015; Clark 
& Sinclair 2008), many health managers in this study expressed concerns about this. It has been 
noted that research which is conducted for individual ends and which does not result in some kind of 
change, at least in knowledge but preferably also in practice, may not be considered valuable, and 
such research may result in research fatigue in the facilities where it is conducted (Clark, 2008). Such 
research fatigue appeared to be an implicit concern for some health managers in this study, and it is 
important that the perceptions leading to this fatigue are addressed, to ensure that socially valuable 
research continues in KZN.  
 
5.2.4 DISSEMINATION AND UTILISATION OF RESULTS 
This stage of the research process, where the results of completed research projects are provided to 
research stakeholders, is crucial to realising the social value of research (Emanuel et al., 2004). If 
research results are not disseminated, so that knowledge is shared and the potential for action is 
created, then the research may just as well not have happened (Senkubuge & Mayosi, 2013). 
Furthermore, failure to disseminate research results may undermine future research efforts 
(UNAIDS/AVAC, 2011).  
 
The poor communication that characterised the relationship between researchers and health 
managers was responsible for the general failure to disseminate and engage with research results as 
perceived by study participants. Poor communication was perceived on both sides of the 
relationship: on the side of health managers who failed to respond to research results when they 
were submitted to them, and on the side of researchers who did not provide reports consistently 
and did not provide results in formats or through media tailored for each specific audience (HPTN, 
2009).  
 
There is a vast literature on the dissemination of research findings, with one systematic review 
identifying 33 frameworks for research dissemination (Wilson et al., 2010). Formerly known as 
‘getting research into policy and practice (GRIPP)’, and currently known as ‘knowledge translation’, 
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this subject has been the focus of intense scrutiny and publication activity over the last few decades 
(Oborn et al., 2010). However, in spite of the abundance of guidance (Wilson et al., 2010) on this 
subject, the dissemination of research findings or the translation of knowledge into practice in South 
Africa has been argued to be poor (Mekwa et al., 2016).  
 
Such literature focuses more on the responsibility of the researcher to actively disseminate his/her 
research findings, and less on the obligation of research stakeholders to engage with these findings 
(Hamlyn, Shanahan, Lewis, O’Donoghue, & Hanson, 2015). However, in Emanuel’s description of 
collaborative partnerships (one of the benchmarks of ethical research) (Emanuel et al., 2004), it is 
clear that such partnerships should be characterised by shared responsibility, including in the 
dissemination and utilisation of research results. The shared responsibility, and the equal ownership 
of the research project, is crucial for the uptake of research results by planners, managers and policy 
makers in the health services, where these results can have an impact on service delivery. Thus 
managers within the Department of Health should accommodate feedback meetings with 
researchers within their schedules, for the discussion of research findings and implications. 
Researchers on the other hand need to be cognisant of the demands on health managers’ time, and 
tailor their feedback on completed projects to formats most accessible to the managers.  
 
5.3 THEME 3: STRENGTHENED RESEARCH 
Respondents from both stakeholder groups shared several similar views regarding ways in which 
research in public health facilities in KZN could be strengthened, at various stages of the research 
process. This theme is discussed in the same sequence, in the light of relevant literature.  
 
5.3.1 CONCEPTUALISATION  
In order to facilitate discussions, regularly-scheduled meetings between researchers and health 
managers were suggested by a number of respondents from both stakeholder groups. Such regular 
forums are already taking place within the TB Directorate of the KZN Department of Health, and 
these were cited by some of the respondents as an example of how such meetings should take 
place. Such forums could ensure that the communication essential to developing collaborative 
research partnerships takes place, but given health managers’ perceived unavailability to engage 
with researchers as described above, it will be important to put mechanisms in place to ensure their 
full participation in these forums. Most guidelines on building inter-stakeholder relations in research 
emphasise the importance of frequent engagement and communication (HPTN 2009; MacQueen, 
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2012; UNAIDS/AVAC, 2011), and the formalisation of meetings may both institutionalise 
engagement between researchers and managers, and improve attendance by health managers.  
 
5.3.2 REVIEW  
A suggestion about which researchers felt strongly was that the different organisations involved in 
review of research proposals (such as ethics committees, the Medicines Control Council (MCC) and 
provincial health departments) should work together so that reviews take place concurrently instead 
of sequentially. This would save a considerable amount of time in the review process. This 
suggestion has already been implemented in the KZN Department of Health. Although final approval 
from the Department is only given once approval from the Research Ethics Committee and the MCC 
is received, clinical trials are reviewed by the Department at the same time as they undergo ethics 
and MCC review (KZN DoH, 2017).  
 
The response to prolonged review, specifically for multi-centre studies, in the United Kingdom has 
been to centralise individual, local RECs into regional multicentre RECs and then to establish a 
Central Office for Research Ethics Committees to co-ordinate these (Mallick & O'Callaghan, 2009). In 
addition, in both the United Kingdom and the European Union, interventions to reduce the period of 
the application process for the conduct of clinical trials have included allowing parallel submissions 
to RECs and the national regulatory authority (Geldenhuys et al., 2012). This has resulted in shorter 
times to approval for clinical trials in these countries (Geldenhuys et al., 2012). However, in the 
United Kingdom at least, ethics and regulatory body review are still sought separately from site 
specific approval (which likely corresponds to the facility or programmatic approval in KZN). Ethics 
and regulatory body approval are sought first, followed by site approval, and this continues to cause 
delays in the process (Kearney et al., 2014). The parallel application process recommended by 
interviewees in this study and recently implemented in KZN (KZN DoH, 2017), may thus provide 
useful information in other research settings.  
 
Another suggestion raised by researchers in this study was that all personnel in the Department of 
Health who are involved in the approvals process, should be better informed about the application 
process for research. Because there is a significant turnover of staff at the facility and district 
management levels, communication needs to take place regularly between provincial research head 
office and district and facility management, to ensure that all staff involved in providing support 
letters to researchers are aware of the procedures they should follow, and of the suggested criteria 
for giving their support to the research projects, and are able to voice their concerns regarding 
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specific research projects. This ongoing capacitation of the staff of regulatory or review bodies has 
been raised as a need by researchers who analysed the time to approval for clinical trials in South 
Africa (Geldenhuys et al., 2012). They argued that limited capacity within the national regulatory 
body was at least in part responsible for the delays and variability in approval times of that body. 
Thus, although RECs in South Africa are relatively well capacitated (Cleaton-Jones & Wassenaar, 
2010), it seems that the other bodies involved in approving health research, including Department of 
Health managers and the national regulatory body, may be less so. Attention should be paid to 
building this capacity at the relevant levels within the Department of Health (and the national 
regulatory body) to avoid delays in approval jeopardising the conduct of useful research.  
 
5.3.3 STUDY CONDUCT  
Health service managers felt that it was important to improve the mechanisms for monitoring 
research conducted in public health facilities including ensuring that informed consents are taken 
correctly from patients, that protocols are implemented as written and no additional research 
questions are added, and that patients are followed up for the correct periods of time. Managers of 
the health services suggested that patients who are also research participants should be followed up 
for longer, to reassure the Department of Health that adverse events due to study participation have 
been ruled out, and will not therefore be the responsibility of the Department to treat. These 
concerns are not unique to KZN, nor to South Africa. In response to research misconduct in Canada, 
authors have suggested that the following should be monitored routinely in all health research: 
regular reviews of research as it takes place, monitoring of the informed consent process, 
monitoring of the adherence to the protocol, and monitoring of the collection and utilisation of the 
data (Weijer, Shapiro, Fuks, & Skrutskowska, 1995). Currently there is little to no monitoring of 
research taking place at public health facilities in KZN, and thus no evidence to reassure managers 
that researchers are adhering to their obligations. Assurance that such processes were occurring as 
they should might build up trust between Department of Health managers, and researchers.  
 
Researchers also suggested that they themselves work on minimising the perception that 
researchers “dump” patients back into public health facilities. In order to rectify this perception, 
they should communicate with the Department of Health in good time, prior to ending a study; they 
should also ensure that prospective patients are registered as Department of Health patients before 
they are recruited into a study, so that when they return to the care of the Department after the 




Both researchers and health managers suggested that Department of Health staff should collaborate 
as research partners, in order to increase the sense of “ownership” of the research by DoH staff, and 
the likelihood that the research results will be utilised. Both groups of interviewees emphasised the 
benefits of involving Departmental staff in research, which included capacitation of these staff, 
increased interest in and attention to research from Departmental staff, and greater likelihood of 
the utilisation of research results. Indeed, it has been shown that “policy makers pay more attention 
to research findings if they have invested their own funds and time” in it (Martens & Roos, 2005, p. 
74).  
 
Health service managers considered that it was important to actively transfer skills to Departmental 
staff during the research process, to increase the value of the research from a Departmental 
perspective, but also to enhance the understanding of Departmental staff of the research process, 
so that a culture of research could be inculcated within the Department. This may enrich the 
research process, and establish greater equality in the relationship between researchers and health 
managers, thus bringing them closer to a truly collaborative partnership as described by Emanuel et 
al (2004).  
 
5.3.4 DISSEMINATION AND UTILISATION OF RESULTS 
Many respondents suggested the hosting of regular formal feedback sessions, in order to ensure the 
dissemination of research results to health managers. This dissemination should not take place using 
only conventional methods such as meetings and peer reviewed publications, but should include the 
use of different media such as newspapers and radio. Research results should not only be 
disseminated to health managers and policy makers but also to the general public (Medical Research 
Council (Great Britain); Opinion Leader Research Ltd.; Wellcome Trust (London, England), 2012). 
Research feedback should be packaged in ways appropriate for specific audiences, including the 
‘sound-bite’ for quick and efficient dissemination such as that delivered on radio (ibid). Stakeholders 
should explore the art of “evidence-based story telling” (Martens & Roos, 2005, p. 78) to enhance 





CONCLUSIONS AND RECOMMENDATIONS 
 
This study aimed to explore the perceptions and practices of key stakeholders (researchers and 
health managers) regarding research conducted in provincial public health facilities in KZN, including 
regarding inter-stakeholder relationships. The study also aimed to make recommendations to 
strengthen the ethical conduct of research, including implementation and uptake of research results 
in public health facilities in KZN, and inter-stakeholder relations. This chapter sets out the 
conclusions of the study in relation to each of these aims, and makes recommendations for various 
stakeholder groups, which include recommendations made by study participants themselves, as well 
as those emerging from the research. Because many of the issues raised by the study were inter-
related, it is likely that the recommendations if implemented will address more than one issue at a 
time. 
 
In terms of the first aim (which was to explore the perceptions and practices of key stakeholders 
around research conducted in provincial public health facilities), this study concluded that, in 
general, both managers and researchers believed that research is important, and that it can have a 
significantly beneficial effect on health and health care. Beyond this level of consensus however, 
important areas of difference were described in two themes – that of the perceptions of these 
stakeholders around the social value of research, and that of perceptions of a strained relationship 
between researchers and health managers (gatekeepers) in KZN. This second theme corresponds 
well with the second aim of the study, which was to explore inter-stakeholder relationships. A third 
theme emerged as often-shared recommendations of the participants themselves, and this 
corresponds well to the third aim of the study, which was to make recommendations for improving 
research processes and inter-stakeholder relations around research in public health facilities in KZN. 
These themes were strongly inter-related. Some of the tensions that both groups of stakeholders 
(researchers and health managers) expressed around their relationships seemed to be rooted in 
their differing opinions of the inherent social value of research, and many of the recommendations 
suggested by both sides focused on communication to facilitate the understanding of these 
differences. Whilst acknowledging the strong inter-relatedness of these themes, the conclusions 






6.1.1 PERCEPTIONS AND PRACTICES OF RESEARCH 
In terms of the first aim - to explore the perceptions and practices of stakeholders around research 
in public health facilities in KZN – this study concludes that stakeholders did not agree on the 
fundamental value of research in these facilities. This disagreement likely impacted how 
relationships between managers and researchers were perceived, at various stages of the research 
process (which is described in section 6.1.2 below).  
 
Interviewees disagreed on why research in public health facilities was valuable. Health managers 
tended to emphasise the immediate benefits of research to health systems functioning, whilst 
researchers tended to emphasise the benefit of research for future patients through its contribution 
to new knowledge. Health managers valued the capacity and infrastructure benefits of health 
research, which corresponds with the so-called ‘collateral’ benefits described by King (2000) as 
distinct from the aspirational benefit to future persons and society arising from results. They 
perceived that research could also have a direct negative effect on the health facilities at which it is 
undertaken, and that there may be considerable burdens related to research in public health 
facilities, such as the use of hospital beds and other public health sector resources, to the detriment 
of public sector patients and staff. Therefore they viewed as less valuable research that undermined 
the facility and its functioning. Researchers on the other hand seemed to feel that any negative 
impact of research on health facilities would be more than compensated for by the general benefit 
of the research, both to the generation of new knowledge and to the facility in general, since some 
researchers did provide resources for the facilities in which they worked.   
 
These conflicting views suggest important differences in how researchers and health managers value 
research. Health managers placed more value on immediate benefits of research to healthcare 
systems than on generation of new knowledge for future benefits. For example, they stressed the 
importance of building capacity of health care workers during research projects. In contrast, 
researchers placed greater value on the generation of knowledge for future long-term use than on 
immediate operational benefits. 
 
Identifying these differences in perceptions regarding the value of research is an important first step 
in better understanding the quality of researcher-gatekeeper relations, for example, why 
researchers and health managers might experience conflict in their relationships. These differences 
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in perceived value might explain certain practices over the research process, and why these are 
perceived as frustrating and unreasonable, to the ‘other side’. For example, researchers expressed 
frustration at the slow research review process – speedy review was reportedly important to 
researchers because research was valued; the speed of review was considered less important by 
health managers who questioned whether research would yield the kind of benefits they value. 
These issues are discussed further under Theme two below.  
 
There has been limited investigation into stakeholder differences in the valuation of research. Social 
value has only recently been articulated as a dedicated ethical requirement for research in ethical 
guidelines (CIOMS, 2016) and ethical frameworks (Emanuel et al., 2000; Emanuel et al., 2004; 
Emanuel et al., 2008). Even in those documents where it is explicitly referred to, the notion that 
research may be valued differently by different stakeholders is seldom acknowledged (Emanuel et 
al., 2004; Emanuel et al., 2008). In the latest iteration of leading guidelines (CIOMS, 2016), social and 
scientific values are identified as two separate entities (CIOMS, 2016). However, social value is still 
defined in these Guidelines in ways that suggest scientific value alone; that is, social value is defined 
as “the prospect of generating the knowledge and the means necessary to protect and promote 
people’s health” (CIOMS, 2016. p. 1) and as “the importance of the information that a study is likely 
to produce” (CIOMS, 2016, p. 1). The notion that some may perceive the most valuable aspect of 
research to be the strengthening of the health service as a by-product of capacity and infrastructure 
development, rather than the generation of new knowledge, is seldom recognised in ethical 
guidelines. However, it is likely that such differences of opinion do occur in other low-resource 
settings (Lairumbi et al., 2012), where the imperative of health managers is to improve their health 
services in resource-constrained environments, rather than to generate new knowledge. Therefore, 
this perception of value should be explicitly considered in early discussions around proposed 
research, so that the conduct of that research is valued by all stakeholders.  
 
This study concludes that the ‘traditional’ definition of socially valuable research may not be shared 
by key stakeholders involved in research in provincial health facilities. Acknowledging that such 
stakeholders (especially in low and middle income countries) may value research differently, and 
identifying what they do value about research, may assist stakeholders to understand each other 
better. This may in turn lead to improved inter-stakeholder relationships, better quality of research 





6.1.2 PERCEPTIONS OF INTER-STAKEHOLDER RELATIONS 
In terms of the second aim of this study, that is to explore the inter-stakeholder relationships around 
research in public health facilities in KZN, this study concludes that the relationships between health 
managers (‘gatekeepers’) and researchers appeared strained, and that perceived tensions in these 
relationships extended across the whole research process; however, tensions were characterised 
slightly differently at various phases (from conceptualisation of the research question, through the 
conduct of the research itself, to the feedback and utilisation of research results).  
 
Health managers and researchers perceived a lack of mutual trust and respect, across the entire 
research process, as well as a failure to achieve a common understanding of the value of research 
over the research process. Reflecting their valuing of the knowledge-generation component of 
research, researchers suggested that research projects did not receive the respectful attention from 
health managers that they warranted. They reported that managers did not avail themselves for 
communication meetings to discuss proposed or ongoing research projects, and they perceived that 
the application process to conduct research at public health facilities was unnecessarily inefficient; 
and that ‘gatekeepers’ at facility level lacked transparency and accountability.  
 
However, health managers (gatekeepers), reflecting their different estimation of valuable research, 
perceived researchers as demanding, inconsiderate of their needs; and centered on their own goals 
whilst disregarding those of the health services. Furthermore, health managers felt that they could 
not trust researchers’ integrity in adhering to their research protocols. These tensions extended 
throughout the research process, including the final stage of dissemination and utilisation of 
research results, which both researchers and health managers agreed was poorly done, although 
both blamed the other for this.  
 
It is recognised that strained inter-stakeholder relationships undermine the conduct of research and 
the utilisation of research results. In Cambodia, tenofovir trials were cancelled because of poor 
communication and misunderstandings between researchers, research participants and gatekeepers 
(Upkong & Peterson, 2009). In South Africa, the poor utilisation of research results is well recognised 
(Mayosi et al., 2012; Senkubuge & Mayosi, 2013). However, in the literature on South Africa, the 
issue of strained relations between researchers and gatekeepers is rarely raised (Singh & Wassenaar, 
2016). Internationally, there is substantial ethical guidance on the development of good inter-
stakeholder relationships in research (Critical Path to TB Drug Regimens Initiative (CPTDRI), 2012; 
UNAIDS/AVAC, 2011). All these ethical guidelines emphasise the importance of similar principles in 
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inter-stakeholder relationship building such as respect, fairness, integrity, transparency, 
accountability, and mutual understanding. However, the guidelines focus on how to ensure positive 
relationships; and the reasons why inter-stakeholder relationships may be poor are seldom 
discussed in such documents. Indeed, in the Good Participatory Practice Guidelines for TB drug trials, 
the lack of empirical evidence informing the development of the Guidelines is acknowledged 
(CPTDRI, 2012).  
 
This study concludes that for these KZN stakeholders, strained relations exist between stakeholders 
over most of the research process. It concludes that different concerns may give rise to these 
strained relations at various stages of the research process. This may provide points at which 
interventions could occur, or at the very least, around which inter-stakeholder conversations could 
be started. This study has suggested reasons for the strained relationships that appear under-
explored in much other literature. Some of these issues may be difficult to talk about, such as the 
lack of trust in the ethical behavior of researchers. However sensitive, it is important that these 
issues are acknowledged, so that they can be discussed and addressed by stakeholders in the future. 
Improving these relationships may assist stakeholders to articulate their view of valuable research 
and help realise the social value of research in KZN.  
 
6.1.3 RECOMMENDATIONS FOR ENHANCED RESEARCH AND RELATIONS  
In terms of the third aim – to make recommendations to strengthen ethical health research in KZN, 
and to improve inter-stakeholder relations – this study concludes that stakeholders from both 
groups share notions about how health research in KZN can be improved, at all its stages. In fact, 
except for the suggestion of punitive measures for researchers who fail to give feedback on their 
research results, there was remarkable similarity between the recommendations made by these two 
groups of interviewees. In this section, the focus is on the recommendations of study interviewees. 
In the recommendations section (6.2 below), both the recommendations of participants and 
recommendations of this investigation are outlined.  
 
Health managers and researchers shared many views about the interventions that might improve 
research generally, as well as their relationships over the research process. Communication was key 
to most of the recommended interventions, such as a technical task team to discuss new research 
concepts, to regular meetings for dissemination and discussion of research results. Communication 
is also an important principle in the Good Participatory Practice Guidelines (UNAIDS/AVAC, 2011), 
70 
 
and this study reinforces the centrality of communication to good inter-stakeholder relationships in 
research.  
 
Capacity building of Departmental staff was also considered important in order to facilitate their 
more equal engagement with researchers. This equality of engagement is arguably an important 
part of ‘collaborative partnerships’, held as the ideal inter-stakeholder relationships for the conduct 
of ethical research (Emanuel et al., 2000; Emanuel et al., 2004; Emanuel et al., 2008). Building 
capacity to facilitate such ‘equal’ engagement is one of the principles of recent ethics guidelines, 
such as the Good participatory practice guidelines for TB drug trials (CPTBDRI, 2012) and the Good 
participatory practice guidelines for trials of emerging (and re-emerging) pathogens (WHO, 2016). 
When the engagement between health managers and researchers is perceived as more equal, it may 
be easier for health managers to negotiate the benefits that they see as important components of 
valuable research.  
 
Improved management of the review process with transparent review criteria and timeous 
responses was considered crucial by researchers whilst improved monitoring of research and 
negative consequences for unethical conduct on the part of researchers was considered important 
by health managers. Indeed, the process of review of research proposals should be held to similar 
ethical standards as the conduct of research (as outlined in research protocols). The principles of 
transparency, responsiveness and accountability should be applied in both. Researchers should 
expect certain standards of protocol review, just as health managers should expect ethical 
implementation of research by researchers. In building better relationships between researchers and 
health managers, standards for the conduct of both groups as outlined in this study could be 
incrementally improved.  
 
This study concludes that the recommendations that interviewees made towards improving the 
research process and strengthening inter-stakeholder relations may be more shared than disparate. 
These recommendations may go a long way to enhancing communication, and building mutual 
understanding and respect between researchers and health managers in KZN. They are the basis of 






A number of recommendations are made in this section for key stakeholders involved in research in 
provincial health facilities, which are not limited to the perceptions of the sample alone. These 
recommendations are linked to the relevant guiding principle in key ethics guidance (UNAIDS/AVAC, 
2011).  
 
6.2.1 RECOMMENDATIONS FOR BOTH GATEKEEPERS AND RESEARCHERS 
A forum to discuss findings from this study related to different perceptions of social value would be 
important, so that a “shared vision” of socially valuable research could be negotiated (Lutge et al., 
2017, p. 132) and “both aspirational and collateral benefits should be articulated and 
accommodated” (Lutge et al., 2017, p. 143)  
 
In order to ensure collective development of regional research priorities and key research questions, 
workshops to build consensus regarding these should take place regularly, for example, every three 
to five years. From these workshops, priority health questions should be identified, which should be 
timeously distributed to core stakeholders (such as academic and research organisations within KZN) 
for uptake by researchers, academics and students. These workshops should be inclusive, so that not 
only researchers, academics and health managers are involved but also other key role-players (cf. 
UNAIDS/AVAC, 2011) such as community representatives, faith based and non-governmental 
organisations and traditional healers.  
 
In order to ensure that the research priorities set are comprehensive and relevant, that the research 
process is acceptable, and the research itself is valued by all stakeholders, the discussions at the 
subsequent workshops should include the following points: gaps in current research (per 
programmatic area in the Department of Health); major emerging health or health systems issues 
(for the province as a whole as well as per district or sub-district); how Department of Health staff 
could be involved in answering these research questions (including issues of capacity building of 
staff, which would increase the social value of the research for managers of affected institutions or 
programmes); where the research could best be conducted (to avoid perceptions of ‘over-research’ 
in certain sites); how the health service could benefit from the research, such as through staff 
development (as above), or health system or infrastructure development (thus also increasing the 




Once research priorities have been identified, researchers and the relevant managers should work 
together to frame the research questions. Regular research forums should be held to discuss 
ongoing research projects. These could be organised per health facility, per health programme (for 
example, TB, non-communicable diseases, etc.), or per geographic area (for example, district or sub-
district), or both. At these meetings, the following should be discussed: concerns from either 
researchers or health managers regarding the conduct of the research (including issues such as use 
of Departmental resources by researchers, and adherence to research protocols; factors 
undermining (or facilitating) the research, and whether the timeframes of the research would be 
affected; interim results of the research; and plans for feedback of final research results).  
 
In order to maintain open channels of communication, regular feedback meetings to present 
research findings to health managers should take place. These should take place in the facility where 
the research took place, as well as district and provincial programme offices. At these meetings, the 
following should be discussed: the implications of the research findings for policy and practice; 
practical ways of incorporating the research findings into Departmental policies and practice; the 
research questions remaining in the field; how these research questions should be prioritised; which 
research question should be addressed next; and how researchers and health managers could work 
together to address the next research question. In this way, meetings for the dissemination of 
research findings could also assist with research translation, and act as forums for research 
prioritisation in the field (also discussed below).  
 
6.2.2 RECOMMENDATIONS FOR GATEKEEPERS  
For health managers at facility or programme level: Health managers should ensure that they 
respond to communication from researchers timeously (where a reasonable limit should be 
negotiated). Where such communication revolves around new research projects, managers should 
ensure that they give input into new projects timeously, so that their valuable experience can be 
used to enhance the project, but also so that the project is not hampered by a delayed response. 
Health managers should within reason, attend all or most of the research meetings initiated by 
researchers. Health managers should be transparent about concerns they have about individual 
research protocols during the request for permission to enter sites and should discuss these with the 
relevant investigators timeously and in an honest manner. Where offers of research mentorship or 
capacity development are given, health managers should accept where possible or decline, 




For the PHREC: The KZN PHREC should make the criteria for approval of health research clear, should 
ensure that these are available in writing and accessible at all times (for example, on a website), and 
should ensure that these are understood by all managers involved in the process of review. When 
management staff change, new employees should be made aware of these criteria and the decisions 
required of them at their level of management. Health managers should take the decisions that are 
delegated to their level of appointment, and not refer such decisions to higher levels 
 
The KZN PHREC should ensure that researchers can apply for Departmental permission for research 
in parallel with their applications to Research Ethics Committees and other regulatory bodies, 
instead of applying to these bodies sequentially, and thus reduce the total research application time. 
The KZN PHREC should establish a research monitoring team, to regularly visit research sites and 
ensure that research is being conducted according to protocol; and reports of these visits should be 
circulated to the relevant health managers. If budgetary constraints prohibit this, the KZN PHREC 
should consider training individuals at research active health facilities to implement this monitoring 
and report on it.  
 
6.2.3 RECOMMENDATIONS FOR RESEARCHERS  
Researchers seeking permission from facility managers to conduct research in their facilities should 
do so respectfully, acknowledging the other demands on managers’ time. Researchers should submit 
their proposals for Department of Health review in good time, to allow gatekeepers sufficient time 
to review and consult on these. Researchers should commit to doing some capacity building of 
Departmental staff during the conduct of their studies; this should be commensurate with the 
duration and complexity of their studies. Capacity building may take a variety of forms, such as 
including a staff member to collaborate on the project, or delivering regular seminars at the 
institution etc. Researchers should follow up their patients for long enough to ensure that any 
sequelae of participation in research studies will be detected, and can be addressed by the 
researchers or organisations conducting the research. During the conduct of the study, researchers 
should refrain from deviating from their protocols, but if this is necessary, should ensure that any 
deviations are reported immediately to the manager of the health facility, district or programme 
concerned. Researchers should be open to monitoring visits from Department of Health officials, 
undertaken to ensure adherence to research protocols.  
 
Also, researchers should be transparent about the Departmental resources that they require, or use, 
during the conduct of research and should be willing and able to reimburse the Department for the 
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use of these resources. Researchers should ensure that their research results are disseminated to 
the relevant managers within the Department of Health, and should avail themselves for meetings 
to discuss these results, or at least respond to electronic or telephonic questions about these results, 
after the study is concluded. Furthermore, researchers should use a variety of media to package 
their research results, so that they are easy to understand, presented in appropriate (non-academic) 
language, and are appropriate for the target audience. Researchers should meet their obligations (as 
outlined in their letters of permission from facility managers) of providing feedback to health 
managers on completion of their research  
 
In summary, this study has concluded that, although researchers and managers agree that research 
in KZN health facilities is important, they disagree about what makes research valuable. Further, 
they report strained relationships across the whole of the research process due to a variety of 
factors, one of which is likely to be diverging perceptions of socially valuable research. The study 
makes a number of recommendations, both as suggested by participants themselves and those 
suggested by the investigator, to strengthen the conduct of research in KZN health facilities and to 
improve inter-stakeholder relationships. Although it is not expected that the process of conducting 
research in KZN, and the relationships between health managers and researchers would improve 
‘overnight’ as a result of these recommendations, it is expected the recommendations may 
contribute towards enhancing trust and mutual respect between these stakeholders, which may in 
turn result in stronger relationships, an improved research process, and research which is highly 
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APPENDIX 1: INFORMED CONSENT FORM 
Dear colleague 
I am Elizabeth Lutge from the KwaZulu-Natal Department of Health. I am conducting a study about 
health research in KZN public health facilities, specifically looking at how key stakeholders perceive 
such research and each other, the practices they engage in, and the impact of such views and 
practices on the entire research process.  
What is the purpose of this study? 
This study aims to explore the perceptions of key stakeholders regarding research in health facilities 
in KZN and the practices they implement, including engagement practices.  
The study aims to make recommendations to improve or strengthen research and stakeholder-
engagement practices for such research.  
Why have you been chosen to participate? 
You are invited to participate because you have experience in the conduct of research in health 
facilities in KZN and your contribution will enrich the results of this study.  
This study will invite a variety of representatives from the health services, research and academic 
institutions in KZN, amongst other stakeholders.  
What will the research involve? 
You will be asked to take part in an interview. The interview is likely to take approximately one hour. 
If you agree, it will be tape recorded. You will be asked questions about your experiences of the 
entire research process as it relates to studies conducted in health facilities in KZN, and your 
experiences of the relationships between various stakeholders in this research, and to identify areas 
that appear to work well, as well as areas that need strengthening.  
Do you have to participate? 
We hope that you will give your time and opinions to this interviewer, so that your views can 
contribute to this process.  
However, you are free to decline. If you decline, this will not be held against you or your 
organisation/facility in any way. 
 You are also free to choose not to answer any questions in the interview if you so wish.  
You may withdraw from the interview at any time.  
If you do participate, are there any risks involved? 
It is possible that you may feel some discomfort discussing your experiences. You are free to decline 
to any specific questions in the interview if you so wish. 
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What steps will be taken to ensure confidentiality? 
Identifying details will be redacted from your transcribed interview.  
Your interview will be assigned a unique number.  
Your anonymized interview will be kept in a separate location from your signed consent form. 
 Your interviewer will not divulge your identify.  
Your name will not appear in transcribed interviews, nor any reports, presentations or publications 
that emanate from this study 
All data (such as transcripts) will be stored in a locked drawer at the KZN Department of Health for 5 
years.  
Electronic data (such as audio-files, electronic transcripts) will be stored password protected. 
What are the benefits of this study? 
Whilst you may not benefit directly from this study, it is hoped that the results will be used to 
improve the research process and stakeholder relationships for such research in KZN.  
Will I be paid? 
This study will only pay for out of pocket expenses incurred by participants and it is anticipated that 
participants will not incur such expenses during this study. 
“Out of pocket” expenses include only reimbursement of mileage travelled in a personal motor 
vehicle, specifically to attend an interview for this study, calculated according to the rates 
determined by the KZN Department of Health.  
What will happen to the results of this study? 
Preliminary results will be presented at a stakeholder meeting.  
Interviewees will be provided with feedback of the main results. 
The results will also be written up in a report for the Head of the Department of Health, and the 
Provincial Health Research and Ethics Committee in the province.  
They will be written up for a thesis as part of a degree at the University of KwaZulu-Natal.  
They may be submitted for publication in a peer reviewed journal.  
Who has approved this research?  




It has also been approved by the Health Research and Knowledge Management Unit of the KZN 
Department of Health.  
Should you have questions about this research, please contact Elizabeth Lutge at 033 – 3952046 or 
elizabeth.lutge@kznhealth.gov.za  
If you have any questions about ethical issues relating to this research, please contact the Social 
Science Research Ethics Committee of the University of KwaZulu-Natal: Prem Mohun at 031 260 
4557 or mohunp@ukzn.ac.za  
 
Declaration 
I, __________________________________________________________ (full names of participant) 
confirm that I understand this consent form and the nature of the study and agree to participate 
 
I understand that I can withdraw from the study at any time. 
 
SIGNATURE OF PARTICIPANT                                                        DATE 
 
__________________________    ______________________________ 
 
Tape recording consent 
 
I, __________________________________________________________ (full names of participant) 
consent to the tape-recording of the interview.  
 
 
SIGNATURE OF PARTICIPANT                                                        DATE 
 
 




APPENDIX 2: REC-APPROVED INTERVIEW SCHEDULE 
INTERVIEW SCHEDULE 
 
The following domains will be explored with all research participants, but depending on the 
participant, more depth will be sought for certain issues than for others.  
 The participant’s current role in the research process 
 
 The participant’s previous/ current experience with research 
 
 The participant’s view of the value/ worth of research, whether/ how it contributes to the 
improvement of health/health care in the province and whether the latter is a valuable goal 
 
 The participant’s perceptions and practices regarding various stages of research:  
 the conceptualization of the research question;  
 the development of the protocol;  
 the approval of the research proposal by the KZN Department of Health; 
 the conduct of the research;  
 the effects of the research on the health facility;  
 the effectiveness or otherwise of the resolution of problems that arise during the 
conduct of the research; 
 the dissemination of the research results; 
 the utilization of research results; 
 factors undermining or facilitating the research;  
 recommendations for improvement. 
 
 The participants views and actions regarding stakeholder relationships including: 
 communication (transparency, frequency);  
 issues related to mutual understanding; trust and accountability; 
 factors enhancing or undermining engagement; 
 recommendations for improvement; 
 impact on research and stakeholder engagement;  
 





APPENDIX 3: INTERVIEW GUIDE 
 
PART 1 
THE FIRST FEW QUESTIONS ARE ABOUT YOUR BACKGROUND AND EXPERIENCES OF RESEARCH 
1. Where do you currently work? 
 
2. What is your role in your institution? 
 
3. What role do you play in any research that is conducted in your institution? 
 
4. Please can you describe some of your experience with research projects in the last 2 years.   
 
5. Please highlight experiences that stand out for you as being important or significant. 
6. Please also highlight positive and negative experiences that stand out for you.  
 
PART 2 
THANK YOU FOR THOSE OBSERVATIONS… 
THE NEXT QUESTIONS ARE ABOUT YOUR VIEWS OF RESEARCH IN KZN AND ITS VALUE 
1. Do you think that health research is important for health in KZN? Why/why not? 
 
2. Do you think health research improves or detracts from population health in KZN? Why/why 
not? 
 
3. Do you think that health research improves or detracts from the delivery of health services 







I’D ALSO LIKE TO FIND OUT ABOUT YOUR EXPERIENCES OF VARIOUS STAGES AND COMPONENTS 
OF RESEARCH IN KZN HEALTH FACILITIES 
 
1. What has been your involvement in conceptualizing research question? 
 
2. What have you experiences been like in developing protocols?  
 
3. What have you experienced with regard to approval of the research proposal by the KZN 
Department of Health? 
 
4. What has it been like for you conducting studies (in KZN facilities?)…? 
 
5. What in your view have been the effects of the research on the health facility?;  
 
6. What in your view are the problems that arise?  
 
7. How are they resolved, if at all?  
 
8. What has been your experience of results dissemination after research? ; 
 
9. What ideas do you have about whether research results are used?  
 
10. What undermines research in KZN facilities? 
 
11. What might strengthen such research?  
 




THE QUESTIONS THAT FOLLOW ARE ABOUT INTERACTION AND COLLABORATION BETWEEN 
RESEARCH STAKEHOLDERS INVOLVED IN RESEARCH IN KZN FACILITIES… 
 
1. What has your experiences been like interacting with other research stakeholders? 
 
2. Can you provide some comments on communication between SHs? 
 
3. What in your view is the level of trust?  
 
4. Any ideas or remarks about accountability? 
 
5. What enhances engagement between key parties? 
 
6. What undermines these relationships?  
 
7. Recommendations for improving relationships? 
 
PART 5 
WE ARE NEARING THE END OF THE INTERVIEW, THANK YOU FOR YOUR HELP SO FAR.  
1. FINALLY, are there any specific incidents or experiences that might illustrate any of the 
above points?  








APPENDIX 4: CODE LIST 
MASTER THEME 1: VARYING PERCEPTIONS OF SOCIAL VALUE 
SUB-THEME: VALUE FOR FUTURE BENEFICIARIES 
o Public/population health: global: generation of new internationally relevant knowledge 
o Public/population health: KZN (local priorities different from global) 
o Public/population health: global: millions of patients benefit 
o Public/population health: KZN: unique problems addressed 
o Public/population health: KZN: unique response to research 
SUB-THEME: VALUE FOR KZN PROVINCIAL DEPARTMENT OF HEALTH 
o Builds people (human capital): capacitates DOH staff  
o Relevance of research: research for academic rather than practical purposes (problematic)  
o Relevance of research: research to solve operational issues 
o Impactful: health systems: help shape interventions 
o Impactful: health systems: add improvements 
o Impactful: clinical care: new drugs registered 
o Impactful: clinical care: development of protocols based on research findings 
o Impactful: exposes DOH staff to new treatments/modalities etc 
o Impactful: health systems help shape improvements 
o Impactful: health systems: research must result in improvements in order to be beneficial  
o Impactful: increases DOH staff awareness of importance of data 
o Material costs, burdens and benefits: research is expensive to conduct  
o Material costs, burdens and benefits: research provides treatment for patients whom the 
DOH would otherwise have had to treat 
o Material costs, burdens and benefits: PDOH does not support research  
o Material costs, burdens and benefits: complex logistics of obtaining funding for research 
(researcher and DOH perspective)  
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o Value for PDOH as perceived by researchers: research is not valued 
o Value for PDOH as perceived by researchers: research is not valued because it may be critical 
o Lack of DOH encouragement/support of research 
o Visible 
SUB-THEME: BURDEN FOR PROVINCIAL DOH  
o Material costs, burdens and benefits: post research burden on DOH when researchers run 
out of funding 
o Material costs, burdens and benefits: post research burden on DOH when patients need 
drugs post trial  
o Material costs, burdens and benefits: Using facility resources: general: researchers exploit 
o Material costs, burdens and benefits: Using facility resources: general: researchers exploit 
and contribute 
o Material costs, burdens and benefits: Using facility resources: general: researchers 
contribute  
o Material costs, burdens and benefits: Using facility resources: general: researchers (should) 
contribute 
o Material costs, burdens and benefits: Using facility resources: general: researchers 
contribute 
o Material costs, burdens and benefits: Using facility resources: diagnostic tests: researchers 
exploit  
o Material costs, burdens and benefits: Using Facility resources: hospital beds: researchers 
exploit  
o Material costs, burdens and benefits: Using Facility resources: DoH staff time: researchers 
exploit  
o Material costs, burdens and benefits: DoH perceptions of researcher wealth 
o Material costs, burdens and benefits: DoH lack of support for research (researcher 
perspective) 
o Material costs, burdens and benefits: DoH perceptions of researcher wealth (researchers 
refute) 




o Causing harm: Undermining  service delivery if DoH staff involved in research outside of 
routine work  
o Excessive research in one facility   
o Interfering with program 
o Relevance of research: Not connecting with program 
o Relevance of research: not implementable by Department 
o Encouraging DoH staff to conduct research : constraints 
SUB-THEME: VALUE FOR ENROLLED PARTICIPANTS 
o Better care: superior to usual care 
o Better care: access to current treatments 
o Better care: improving access to new treatments 
o Better care: more individual attention than usual care 
o Material costs, burdens and benefits: incentive for trial participants but not for other 
patients 
 
MASTER THEME 2: STRAINED RELATIONS  
CONCEPTUALISATION 
o Partnership: Importance of involving DoH at conceptualisation of research question 
o Communication: Developing research question 
o Communication: Obtaining support for grant applications 
o Communication: Agenda setting 
o Communication: relationship building 
o Communication: lack of communication with researcher and hospital departments affects 
hospital planning  
o Communication: lack of inclusiveness 





o Review: regulations from ethics committee 
o Review: Danger of DoH as ‘gatekeeper’ 
o Period for review: lengthy 
o Period for review: lengthy: result of poor DoH research literacy 
o Period for review: lengthy (outlying view) 
o Period for review: justification for (DoH perspective) 
o Period for review: lengthy, onerous 
o Period for review: impact of for research grants 
o Period for review: rapid or lengthy 
o Duplication of review: lengthy because of sequential reviews by various bodies  
o Duplication of review: lack of trust between regulatory bodies 
o Transparency 
o Transparency: failure to inform researchers of new application form 
o Transparency: DoH decisions not transparent 
o Transparency: failure to inform researchers of reasons for re-submission 
o Accountability: failure of regulatory body to look after submissions 
o Accountability: variability in quality depending on person involved 
o Accountability: Failure of DOH staff to honour meeting appointments 
o Communication: general 
o Communication: lack of communication between regulatory bodies 
o Communication: easy communication with regulatory bodies facilitates application process 
o Communication: variability in quality depending on person involved 
o Communication: within DoH re review process (poor) 
o Communication: within DoH re review process (poor); responsibility in DOH for taking 
decisions (lack of) 
o Communication: regarding review from DoH to researcher 
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o Trust: lack of trust between regulatory bodies 
o Fairness: Faster process if personally acquainted with DoH representative 
o Fairness: length of review process arbitrary, unpredictable 
o Review at provincial level with NHRD 
STUDY CONDUCT 
o Power relations: DoH staff diffidence 
o Power relations: superior researcher knowledge  
o Power relations: superior researcher knowledge OR research literacy DoH staff  
o Power relations: DoH staff inexperience OR research literacy DoH staff  
o Power relations: only senior DoH staff conduct research  
o Trust  
o Trust: Long term unintended effects of research fall on DoH 
o Trust: relationship built over long period of time 
o Trust: Not trusting researchers to inform/ feedback to DoH  
o Trust: Mistrustful of researchers motivation: money-making 
o Trust: Mistrustful of researchers’ motivation: getting degrees 
o Trust: Not trusting researchers to report problems, adverse events 
o Trust: Not trusting researchers’ conduct research as per protocol 
o Trust: Not trusting researchers’ conduct research as per protocol: to do informed consent as 
stated 
o Trust: Not trusting researchers conduct research as per protocol: safeguarding data 
o Trust: Not trusting researchers conduct research as per protocol: anonymizing data 
o Trust: takes time to build in relationship  
o Communication: must be constant to avoid misunderstanding 
o Communication: several lines of within DOH 
o Facility resources: hospital beds: researchers exploit 




o Material costs, burdens and benefits: use of facility resources: staff time: researchers exploit 
o Value for PDoH as perceived by researchers: research is extraneous to/competing with 
service-delivery  
o Value for PDoH: research perceived as criticism 
o Value for PDoH:  research is exposing problems within DoH therefore is not valued 
o Builds people/capacity development 
o Partnership between researcher and DoH staff 
DISSEMINATION 
o Transparency 
o Implementation of results: effect in the real world 
o Implementation of results: timeliness and effectiveness of implementation 
o Feedback/dissemination of results: 
o Feedback/dissemination of results: researchers do not feedback to DoH 
o Feedback/dissemination of results: researchers feedback to DoH variably 
o Feedback/dissemination of results: researchers do not feedback to DoH well 
o Feedback/dissemination of results: DoH hears about research results elsewhere, not from 
researchers 
o Feedback/dissemination of results: DoH does not engage with results 
o Feedback/dissemination of results: DoH does not facilitate feedback 
o Feedback/dissemination of results: DoH does not facilitate feedback; Accountability: Failure 
of DOH staff to honour appointments and to return calls 
o Feedback/dissemination of results: making results accessible/understandable  
o Feedback/dissemination of results: DoH is overlooked by researchers in favour of other 
forums 
o Feedback/dissemination of results: DOH does not facilitate feedback; Accountability: Failure 
of DOH staff to honour meeting starting times 
o Accountability: Failure of DOH staff to honour appointments and to return calls 
o Even in feedback session organized by DOH facility, poor researcher participation 
o Utilisation of research results: results are used to change protocols 
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SUB-THEME: RESEARCHER-RESEARCHER RELATIONS 
o Trust: don’t trust other researchers to behave ethically 
o Competition between researchers 
o Competition between researchers: Territorialism 
MASTER THEME 3: STRENGTHENED RESEARCH AND RELATIONS 
CONCEPTUALIZATION 
o Agenda-setting 
o Use of public health physicians 
o Discussion group/forum 
REVIEW 
o Review: enhancing review process 
o Review: enhancing review process: clarifying responsibilities at all ‘gatekeeper’ levels 
o Review: Training/capacity development  for facility gatekeepers 
o Review: concurrent review processes 
STUDY CONDUCT 
o Improving process of conducting research  
o Capacity development: encouraging DoH staff to conduct research 
o Capacity development: encouraging DoH staff to conduct research: preference to people 
from middle and lower income countries 
o Capacity development / research literacy for DoH staff 
o Capacitation of researchers: ethics training to improve ethical behaviour 
o Obligation for DoH staff to conduct research 
o Material costs, burdens and benefits: Need for funding for DoH staff to conduct research 
o Encouraging research in DoH: providing incentives 
o Encouraging research in DoH: capacity building 
o Encouraging research in DoH: providing incentives (academic) 
o Encouraging research in DoH: capacity building received 
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o Encouraging research in DoH: need for DoH support 
o Encouraging research in DoH: make research part of DoH staff performance agreement 
o Impact on health services: need for researchers to dovetail with routine services 
o Trust: Not trusting researchers to monitor themselves 
o Monitoring and Evaluation: Need to improve monitoring of research by DoH:   
o Monitoring and Evaluation: need to ensure proper informed processes are followed by 
researchers 
o Monitoring and evaluation: spot checks to ensure researchers are conducting research as 
per protocol 
o Monitoring and evaluation: ensure detection of adverse events or other problems during 
research 
o Longer post-trial follow up of patients to ensure unintended effects of research are detected 
DISSEMINATION AND UTILISATION 
o Feedback/ dissemination of results: organize formal feedback sessions to DoH 
o Feedback/ dissemination of results: Use newspapers and other media to disseminate 
research results 
o Feedback/ dissemination of results: regular feedback to DoH regarding stages of ongoing 
research and results of completed research  
o Feedback/dissemination of results: penalize researchers who do not feedback results to DoH 
o Feedback/dissemination of results: enforce dissemination of research results 
o Feedback/dissemination of results: committee to review research results and guide 
implementation 
o Research literacy: broad social education around research 
o Utilisation of research results: ensure research is relevant to maximize utilization of results 
o Utilisation of research results: ensure DoH understands  value of research to improve 
utilization of results  
o Working together, relationships: ensure all stakeholders understand their roles in research  
o Communication: ensure all stakeholders understand value of research and how it can 
benefit each 
APPENDIX 5: 
ETHICS APPROVAL (BIOMEDICAL RESEARCH ETHICS COMMITTEE)
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